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INTRODUCTION 
Siddha system is one of the oldest system of medicine in india.The term Siddha 
comes  from “Siddhi” means  attainment of perfection.It is an ancient traditional system 
of medicine developed   by 18 Siddhars who glorified human beings as the highest form 
of birth and believed  that to preserve human body is essential to achieve eternal bliss 
Siddha medical literatures are in tamil and it is practiced in tamil speaking parts of 
India and countries like Srilanka, Malaciya and Singapore. 
The Siddha system is also called Agasthiyar maruthuvam in the name of its 
famous exponent sage Agasthiyar.A huge number of medical works of siddha system are 
ascribed to him but it may be difficult at  this  time to sage Agasthiyar. Siddha system of 
medicine developed only with in the in Dravidian culture of prevedic period, and it is 
largely therapeutic in nature. 
 The Siddha medical science is based on the principles panchaboothas (the five 
elements) 96 thathuvas and thridosh as  (three humors)  
“Prevention is better than cure” 
Hence a separate chapter has been described in our system,for preventing the 
diseeses,under the heading “Pinianugavithi” 
 
@jpz;zkpuz;L s;ns rpf;f tlf;fhkw; 
bgz;zpd;gh byhd;iwg; bgUf;fhky; ? cz;q’;fhy; 
ePh;RUf;fp nkhh; bgUf;fp bea;a[Uf;fp a[z;gth;jk; 
ngUiuf;fph; nghnk gpzp@ 
? gjhh;j;j Fz rpe;jhkzp 
? njiuah; 
 
Siddha system believes that every thing in the universe are made up of five basic 
elements earth, water, fire, air and space  which also constitutes the human body and 
other world by substances. This system describes 96 principles constituents of human 
being, which include physiological, physical,moral and intellectual components of 
individuals, when there is any imbalance or slight deviation  with  these 96 phylosophical 
units, diseses occur. The diagnostic ostic methodology in siddha system is derived from 
eight fold examinations including examination of pulse, tongue, complexion, speech, 
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palpatory findings etc. perception has a great role in the venture that can be achieved by 
the sense organs, by mind, by yoga, by pain and pleasure 
Children’s are future citizens  hence  their health is of paramount   importance to 
our nation.Care of Children  is different  in many  aspects  from adults so a separate  
Branch of Medicine “Balar maruthuvam” (or) “Pillaipini maruthuvam” (or)  
“Balavagadam”  has been deals  by our ancient saints siddhars. 
Hence health care of children should be actually started well before the child 
appears as an individual in the world .when it is a zygote in the mother’s womb. So, the 
care of a pregnant women is also a part of child care.Siddha system deals   with the 
diseses  that encounter  a women during  pregnancy  under the heading “Pindorpathi “   
and also describe specific treatment for the specific diseases. 
Pillaipini maruthuvam is an important branch of medical science of written by 
Siddhars, which deals with the diseases and treatment aspects of  children. 
In the text book of Balavagadam  - A Siddha  paediatric literature, the disease of  
children  are broadly  classified into Aga karana noigal and Pura karana noigal. 
Among the Purakarana noigal “Kanakazhichal” is  a commonly occurring  disease  
in  infants and children. It is a disorder of Gastro intestinal tract caused by micro 
organism  due to poor personal hygiene and sanitation. Ultimately leads to dearangement 
in Tridosas  and disease manifestations occur. 
It has been clearly  depicted in Gurunadi nool (Shanmugavelu-1987) that 
kanakazhichal is caused by kirumigal (micro organisms) and explained in siddha 
literature are  more  or less  related to  Bacillary dysentery  described  in modern  system 
of medicine. 
Annually, these are 165 million reported or confirmed cases of Bacillary 
dysentery and 1.1 million deaths world wide, predominantly in developing countries. 
(Ncbi.nlm nih.gov).  60% of such death occurs are seen in under 5 children. 
So the author interested to take Kana kazhichal  is Dissertation subject with  trial  
medicine  Mookurattai ennai  which is a sample, pure herbal preparations. 
This dissertation is a through study of the disease “Kanakazhichal” in 40 patients 
admitted in the post graduate department of Kuzhandhai maruthuvam  op at Ayothidoss 
pandithar Hospital  of  the National Institute of Siddha, Chennai-47. 
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AIM AND OBJECTIVES 
 
AIM:  
 To evaluate the clinical efficacy of Mookurattai ennai in the treatment of 
Kanakazhichal  (Bacillary dysentery) in children” 
 
OBJECTIVES: 
 Primary objectives:  
To determine the therapeutic potential and effectiveness of the trial drug 
Mookurattai ennai in treating of  Kanakazhichal in children. 
 
Secondary Objectives : 
Ø To collect the literary evidences  of  Kanakazhichal as per Siddha system. 
Ø To review the scientific literatures of the disease Bacillary dysentery in respect of 
etiology, pathology, clinical features, treatment, complications and prognosis. 
Ø To find out the incidence of Kanakazhichal in regard to low socio-economic 
condition, poor hygiene, and malnutrition. 
Ø To findout the impact like diet, land, climatic conditions and personal hygien 
(Unavu, Thinai, Paruva kaalangal and Ozhukkam) in the incidence of 
Kanakazhichal. 
Ø To correlate the sign and symptoms, etiological factors of Kanakazhichal with 
Bacillary dysentery in  modern literature 
Ø To evaluate the  efficacy of trail medicine on Anti microbial activity by in-vitro 
methods 
Ø To evaluate Physicochemical Analysis and Phytochemical analysis of trail drug. 
Ø To made awareness among the patients / parents regarding this disease and its 
prevention. 
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REVIEW OF LITERATURES 
SIDDHA ASPECT 
,ay;  
 tapW fLj;J mof;fo rpwpjhnaDk; my;yJ tapw;Wf;fLg;g[ mjpfkpd;wp mst[ 
fle;njDk;. rPjf;fl;Lk; FUjpa[k; TonaDk; fHpa[k;  
 
neha; vz;/ 
Classification of Kazhichal based on various siddha literatures:- 
1. In balavagadam three types of kazhichal noigal have been described. 
(i) Mantha Kazhichal 
(ii) Kana Kazhichal 
(iii) Seethak  kazhichal  
2. At the same time 7 types of Kazhichal noigal was explained along with treatment 
in Balavagadam-Siddha  paediatric text book,  
1. Veppu kazhichal 
2. Ratha kazhichal 
3. Adhisara kazhichal 
4. Kaduppu kazhichal 
5. Pachilai kazhichal 
6. Vida kazhichal 
3. In T.V Sambasivam pillai dictionary, the following Kazhichal noigal have been 
mentioned. 
1. Seedha kazhichal 
2. Ratha kazhichal 
3. Sala kazhichal 
4. Soba kazhichal (Diarrhoea with great weakness and exhaustion) 
5. Veeludai kazhichal (white diarrhea) 
6. Vayettu kazhichal(Gastrogenic diarrhea) 
7. Sangara kazhichal(Diarrhea with various symptoms) 
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4. In Athma Rakshamantham  literature  also called Vaidhya Saara sangirakam 
fifteen types of  kazhichal  classified. 
 
@brhy;Yfpnwd; fHpr;ry;tif nfhtpe;jd;id 
  fHpkhe;j fHpr;rydr; brg;gyhFk;  
 bty;Yfpnwd; ghw;fHpr;ry; tul;fHpr;ry; 
  tPwhd the;jpapd;jd; fHpr;ryhFk;  
 ky;Yfpnwd; fzf;fHpr;ry; khe;jfHpr;ry;  
  g[fHhd Mkj;jpd; fHpr;ryhFk; 
 bfhy;Yfpd;w ryf;fHpr;ry; btJg;g[f;fHpr;ry; 
  Twhd uj;jj;jpd; fHpr;ryhnk@   
 
 @Mnkjhd; mjprhuf; fHpr;ryhFk; 
  mg;gnd bghUkypd; fHpr;ryhFk; 
 nghnkjhd; rPuj;jf; fUg;g[thFk; 
  bghy;yhj fHpr;rbyd;W ehbka;Jk; 
 jhnkjhd; gr;rpiyf; fHpr;ryhFk; 
  rhh;thd tplf;fHpr;ry; rhw;wyhFk; 
 ehnkjhd; brhd;ndhnk fHpr;ry; khh;f;fk; 
etpd;wpl;lhh; ghyUf;F etpd;l;lhnu@ 
 
1. Suzhimantha kazhichal 
2. Paal kazhichal 
3. Varat kazhichal 
4. Vaanthi kazhichal 
5.  Kana  kazhichal 
6. Maantha kazhichal 
7. Amakazhichal 
8. Sala kazhichal 
9. Vethuppu kazhichal 
10. Rattha kazhichal 
11. Athisara kazhichal 
12. Porumal kazhichal 
 
 
6 
 
13. Ratha kazhichal 
14. Pachilai kazhichal 
15. Vida kazhichal 
 
5. Two types of Kazhichal have been described in literature  Pararaja sekaram 
balaroga nidhanam. 
1. Vayitru kazhichal 
2. Vayitrulaivu  
6. In Jeeva Rakshamirtham, the following kazhichal noigal are given 
1. Rattha kazhichal 
2. Sala kazhichal 
7. In  the literature  noi nidhanankal, ten types of kazhichal noigal are given. 
1. Moola kazhichal 
2. Vatha kirani 
3. Pitha kirani 
4. Seetha kirani 
5. Vatha pitha kirani 
6. Pitha Sethuma kirani 
7. Vatha seetha kirani 
8. Thontha kirani 
9. Vayettru Kaduppu 
10. Vayettru kothippu 
8. According to Agathiyar Vaidya Kaaviyam 1500, Kazhichal is classified into six 
types. 
@ fHpr;rbyd;w fpuhzpapny tpjkhwg;gh 
fz;l gpj;jk; mdy; thjk; tha[thFk; 
mHpr;rbyd;w ngjpf;Fk; ghh; bgyk;  nghFnk 
bjHpr;rbyd;w tha[jhd nkfngjp 
jpwkhd K:yj;jpd; njhlngjp 
gHr;rbyd;w r’;fhd ngjpbahd;W 
ghug;gh tha[bthd;W MWkhr;nr@ 
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1. Vatha kazhichal 
2. Pitha kazhichal 
3. Kaba kazhichal 
4. Moola kazhichal 
5. Sangana kazhichal 
6. Mega kazhichal 
9. Same classification has been given in Thirumoolar Vaidhyam”  Karukkidai 600. 
 @ fHpr;;byd;w fpuhzp fhqk; tpjk; nfS  
   mHpr;rpa gpj;j kzy; thj ikakhk; 
  brGr;rpa tha[ njh;e;jpit K:d;whny 
   gHpr;brd ngjpf;Fk; ghh;  bgyk; nghFnk@ 
 @ bgykhd nkfj;jpw; gpwe;jbjhU ngjp 
    Fykhd K:yj;jpw; bfhoabjhU ngjp 
    Rfkhd tha[thw; r’;fpj;bjhU ngjp 
      t[ykhdjhYk; tFj;j Kiwahnk@ 
From the above verses it is clear that  many authors described  the types of 
kazhichal noikal. But the  author selected   the dissertation topic Kanakazhichal    from  
Balavagadam. 
 
Noi Varum Vazhi (Etiology) 
The causes for Kanakazhichal mentioned in various siddha test are as  follows: 
1. Intake of the food stuffs which are easily not digestible. 
2. Intake of excessive pungent and sour tasted food stuffs. 
3. Taking sweets, mutton and improperly cooked food stuffs. 
4. Taking medicines which are having poisonous effects ( 
Karamarumdhugal) 
5. Drinking impure water like sunaineer  
6. Wandering in hotsun  and exposure to cold air. 
7. Living in over crowded areas. 
8. Suffering from seetha suram 
9. Improper treatment taken for Athisara noi . 
The above  mentioned causes are stated  as  following verses in Yugi chinthamani text 
book. 
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                  @ khbdd;w tapw;wpy; khjkpUf;Fk; nghJ  
   khg;gz;l kJu’;fs; k’;if nfh&;o  
  csbdd;w khkpr’;fs; ntfhg;gz;lk; 
   cz;ljhw; fpuhzp te;Jw;gtpf;F’; fz;lha; 
      ?a{fprpe;jhkzp 
jhdhf cz;lhf tpjj;ijf; nfsha; 
juzpjdpw; Fsph;r;rpa[ld; tplrj;Jj;jhDk; 
njdhf kpFjpdp g[rpj;jhYk; 
jpuz;l fsf;Tl;lj;jpy; nghtjhYk; 
khhd rPjRuhy; fhqk;nghJ 
kfj;jhd ,sneha[z;lh bkd;W 
nfhdhd Ehy;jdpny bghpnahh; brhd;dhh; 
bfhw;wtnd ajpDila Fzj;ijf; nfns@ 
                                 ?mfj;jpah; Fztflk; 
 
Gurunadi book explains the causative organism and the pathogenesis of the 
disease Kanakazhichal. 
 
@nfSkpdpf; fphpkpahy; te;j fpuhzpiaj;jhd; 
     fpUiga[ld; K:yj;jpy; ntt[ bfhz;L 
   ehSkJ fpUkpajpd; Fliyr; Rw;wp  
      uj;jKz;lh”; Rnuhzpj;jjhy; kyK’;fl;o 
     kPStJ tha;t[ brd;W tputpj;jhDk; 
    tputpa’;nf fye;jpUf;fpy; fpUkpbay;yhk; 
   nfSkJ gytpjkha;f fHpa[k; gyh;  
    Fo bfLj;j fpUkp bra;j fpuhzpjhnd@  
 
Due to excessive  heat the pathogenic microorganisms (kirumigal) multiplies in 
large numbers in the intestine. They make the stools dry, decomposed and producing foul 
smelling gases (vayu). Then it produces kazhichal. 
Murkuri Gunangal (Premonitary symptoms): 
Headache, Nausea and pain in the abdomen, burning sensation in the arms, 
tenesmus due to increased peristaltic movement are the symptoms produced in the initial 
stage of the disease. 
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Pothukurigunangal (General signs and symptoms): 
· Passing of loose stools containing small amounts of microbes. 
· Pain in the abdomen 
· Rumbling sounds in the intestine 
· Burning sensation in anal  area. 
· Tenesmus 
Besides passing of loose stools with mucus , frequent scanty stools are present during 
that time intense abdominal pain and rumbling sounds in the intense is observed. Due to 
severe pain, the patient will be always in sitting posture. Naadi appears week and 
perspiration is sun. 
The above mentioned features are stated in siddha maruthuvam 
 
fzf;fHpr;ry; 
@rPj’; fHpa[ ky’;fHpa[k; jpUk;gpf; bfl;l ghy;nghny 
 nghjf; fHpa[’; fwpj;jz;zPh; nghY’; ifa[‘; fhy; Fsph;e;J 
 fhij ailf;Fk; btJg;g[z;lhk; ifapw; gps;is j’;fhJ 
 nfhjh ape;jf; fz;’;fz;lhy; Fyt[ kjd;ngh; fHpfdnk@ 
                                             - ghythflk; 
rPjkhf fHpa[k; my;yJ kykhf fHpa[k;. ,t;tpjkpd;wp bfl;Lg;nghd ghy; 
nghyt[k; fHpa[k;. fwpj;jz;zPh; nghyt[k; fHpa[k;. iffhy; Fsph;e;J ,Uf;Fk;/ fhJ 
milf;Fk;. Ruk; fha[k;. gps;is ifapy; j’;fhJ nghd;w FwpFz’;fs; fhzg;gLk;/           
Patient may  have gripping pain in the abdomen, with irritation in and around the 
anal region, rectal tenesmus with loose stools, pool appetite and weakness of the body due 
to excessive loose stools. 
The same features have been described in  the text Agathiyar 2000. 
 
 @,Lg;g[ fLj;J tapWise;J ,sF”;rPjkhw;wPe;J  
KLff;Fj;jp Kf;fp JauKfkha; cz;zh  Kynk fHpe;jl’;Fk; 
mLe;njhud;de;jd;id njlh fwnt bkype;J  tUe;bjhLf;Fk; 
tapw;Wf;fLg;bgd;W brhd;ndhe;j; bra;a[k; Jah;fz;nl 
        ? mfj;jpah; 2000 
 
Patient having  fever with abdominal pain, loss of appetite, loose motion with 
nerves, general weakness and shivering. 
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Mukkutra Verupadugal (Pathology): 
According to siddha system of medicine, diseases are produced due to 
derangements in thridoshas (ie) vatham, pitham, kabam. 
The siddha concept of pathology of kanakazhichal have been described in 
Thirumoolar karukkidai 600 
 
@fHpr;ry; ,uhzp fhqk; tpjk; nfS 
   mHpr;rpa gpj;jk; miythjk; Iakhk; 
  brGr;rpa tha[ nrh;e;jit K:d;why;  
   g[Hpr;brd ngjpf;Fk; ghh; bgyk; nghFnk 
      jpUK:yh; fUf;fpil ?600  
 
In kanakazhichal due to various causes stated above, the pitha kuttram is vitiated 
from its normal conditions. This is turn stimulates abanan, a type of vatha. Also saaram 
are affected. 
Vitiated pitham along with kabam causes passage of loose stools with mucus. 
Pain in the abdomen and tenesmus are produced mainly due to vitiated vayu. 
Finally all the trithathus are deranged from their normal positions and produces 
muppini noi. 
 
Piniyari muraimai Diagnosis: 
 In Siddha system of medicine, diagnosis of a disease is made up on the following 
principles, 
1. Poriyaalarithal  (Inspections) 
2. Pulanaalarithal   (Palpation) 
3.  Vinaadhal  (Interrogations) 
Pori are the five organs of perception namely nose, ears, tongue, skin and eyes. 
Pulan are the five objects of senses namely smell, sound, taste, sensation and 
sight. 
Poriyaalarithal and pulanaal arithal goes hand in hand with concept of examining 
the patients pori and pula with that of the physician’s pulan and pori. 
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By vinaathal, the physician knows about the patients name, age, native place. 
Socio economic status, family history, dietic habits etc., 
It is infants or child or unable to talk (deaf and dumb) the patient  history are 
obtained from his / her relatives or parents (informant) 
Poriyaalarithal, pulanaalarithal and vinadhal are  implemented   through envagai 
thervugal.(Eight fold examination). 
 
Envagai thervugal  (Eight fold examination). 
 According to Siddhars Envagai thervugal is considered to the important tools  of 
a physician.  
@ eho !;ghprk; ghy;  epwk; bkhHp tpHp 
  kyk; Kj;jpukpitkUj;Jtuha[jk;@ 
 
 eho              (pulse) 
 !;ghprk;  (palpation) 
 eh   (tongue) 
 epwk;       (colour of skin) 
 bkhHp           (speech) 
 tpHp                   (eyes) 
  kyk;            (Stools) 
          K:j;jpuk;         (urine) 
 
 
Naadi (Pulse) 
Naadi is an important observation for diagnosis and prognosis. Naadi is 
responsible for existence of life and can be felt one inch below the wrist on the radial side 
by means of palpation with the tips of index middle and ring fingers  of the physician   
corresponding to Vadham, Pitham and Kapam 
Normally the three humors Vadham, Pitham and Kapam exist in the ratio                
1:1/2 : ¼  
The derangement in these  ratio leads  to various diseases. It is best diagnosed by 
feeling the Naadi in radial artery. 
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Naadi Nadai in Kana Kazhizthal 
@bjhe;jpj;j rpnyw;gdj;jpy; tha;t[ Toj; 
  Jlh;e;j Fd;kk; be”;rilg;g[ Rthrfhrk; 
te;jpj;j Fuy; jdpny t[Wj;jyPis  
tGtGg;g[ ePUwy; kyj;jpy; rPjk; 
bte;jpujk; bfhGj;jy; Fj;Jj;jpkph;tpahjp 
tPr;Rlnd typbal;Lz;l; jpul;ir ghz;L 
me;jpj;j FWFWg;g[ kaf;fk; tpf;fy; 
 Mdgy gpzpa[k; te;jlWe;j jhnd@ 
  
 Deranged  Kabam with Vaayu produces the stools  mixed with mucus. Naadi 
Nadai for the disease  Kiraani  may also responsible for Kana Kazhichal 
 
@rpwg;ghd gpj;jjpy; thjp eho 
 nrupYWe;j jhJ el;lKju gPil 
 ciwg;ghfr; brhpahikf;Fd; k”;Niy 
  a[w;w Ru’;fuhzp tapw;wpiur;ry; ke;jk; 
 miwg;ghd X’;fhu g[wdPw;fnfhit 
  Mahr kpuf;f bkhL kaf;f K:h;r;ir 
 Kiwfha;t[ tp& tPf;fk; K:ytha;t[ 
  Kulhd neha; gyt[KLFk;  gz;ng@  
In Pitha vaadham Kiraani is produced. .If the deranged pitham combined  with 
vatham,  the kirani will produced. 
When there is aggrevated Vadha Naadi the disease Kriraani is produced. 
 
@thjbkDk; ehoaJ njhd;wpy; btg;g[ 
rPjke;jbkhL tapW bghWky; jpwl;rp tha[ 
rPjKW’;fpwhzp knfhjuk; ePuhik 
jpus;tha;t[ Niy typfLg;g[ jPiu 
ePjKU’; fpUkpFd;kk; mz;lthjk; 
epiya[k; ePh;fhpr;ru’;fs; je;J nkfk; 
ngjfkh Kjugpzp K:ynuhfk; 
ngr btFgpzpfSnk bghUsjhnk@ 
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Naa (Tongue) : 
 In the examination of tongue ,colour, coating wetness or dryness, deviation, 
fissures. Variation in taste, condition of teeth and gums are carefully noted. 
In Kana Kazhichal coated tongue shows indigestion and loss of appetite and 
sometimes pallor may be noted.  
 
Niram (colour): 
Colour  of a human body  may indicate the physique  type like   vatham, pitham 
kabam and thridhodas. Cyanosis, pallor, yellowish, discolouration of the body  also  
observed through this. 
In Kana Kazhichal  there is no colour changes in the body. 
 
Mozhi (Speech): 
In the examination of mozhi , the pitch of voice (high or low), laughing, slurring, 
speech in hallucination , crying, breathlessness or wheezing and incompleteness while 
talking may be noted. 
In KanaKazhichal mozhi may not be affected. 
 
 
Vizhi (Eyes): 
Both sensory and motor disturbances are noted. Colour, inflammation, ulceration, 
sharpness of vision, lacrimation, response of pupil to light may also be noted.    
In KanaKazhichal pallor of eyes sometimes  noted. 
 
Sparisam (Skin):  
     By sparisam , the temperature  of skin (heat or cold), smoothness, roughness, hardness, 
sweat, dryness, swelling, tenderness, ulcers and pigmentation can be examined 
     In Kana Kazhichal raised body temperature may be present some times. 
 
Malam (faeces): 
In the examination of malam , Niram(colour), Nurai(froth), Erugal(solid), 
Elagal(Semi solid or liquid), quantity(increased or decreased), smell can be noted. Other 
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examinations like diarrhea, presence of blood or mucus or undigested  food particles in 
stools and odour can also be noted. 
In KanaKazhichal the stool  is  liquid or semisolid, large or scanty in quantity, 
greenish or brick red or dark brown in colour, sometimes it gives offensive odour 
containing blood or mucus. 
 
Moothiram (Urine): 
In the examination of urine, colour, odour, quantity of urine, the presence of froth, 
deposits, blood, and pus abnormal constituents such as sugar, protein etc. and frequency 
of urination can also  be noted. 
In KanaKazhichal the quantity of urination may be slightly deminished. 
 
Neerkuri: 
te;j ePh;f;fhpbail kdk; Eiu v”;rbyd 
iwe;jpa Ysit aiwFJ Kiwna 
 
      -rpj;j kUj;Jth’;f RUf;fk; 
 
According  to this verse, the general features of urine or niram, edai, manam, nurai, enjal. 
ü Niram indicates  the colour of the urine voided 
ü Edai indicates the specific gravity of the urine 
ü Manam indicates the smell of the urine voided 
ü Then nurai indicates the frothy nature of urine voided 
ü Then enjel indicates the quality of urine. 
 
Collection of urine for Neikuri 
@ mUe;Jkh wpujKk; mtpnuhj kjha; 
  mf;fy; myh;jy; mfhyt{z; jtwpe;jHw; 
  Fw;wstUe;jp cw’;fp itfiw  
 Mof;fyrj; jhtpna fhJ bga; 
 bjhUKTh;j;jf; fiyFl;gL ePhpd; 
  epwf;Fwp bea;Fwp epUkpj;jy; flnd@ 
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Prior to the day of  neerkuri  examination, the patient asked to take a regular and 
balanced  diet without any derangement in amount and quality. The patient is allowed to 
have a good sleep. In the next day early morning , the first voided urine  is collected in a 
glass contained  for analysis. 
 The examination  should be carried out in one and half hours. A drop of Gingelly 
oil is dropped into a  vessel containing the urine and  kept in the bright light in a calm 
place without shaking.  The derangements of three thathus is studied by the  nature of oil 
on the surface of urine. 
  
@ mbubtd ePz;ood; m`Jbt thjk; 
  MHpnghw; gutpd; m`Jbt gpj;jk;  
  Kj;bjhj;J epw;fpd; m`Jbt fgk;@ 
 
If oil spreading like snake a  indicates Vadham 
Oil spreading like ring it  indicates Pitham 
Oil floating as pearl  then it  indicates kabam 
 In Kana Kazhichal oil spreads like a snake or pearl and  indicating of vaadham 
and kabam. 
Complications: 
If the above diseases are associated with Kiraani it may leads to a fatal outcome. 
 
@ghz;L gpunkfk; gd;thj NiyFd;kk; 
 ntz;lh &a”;rd;dp btz;nrhig?  dPz;l 
 mjpdPnu fhkhiy  ahdgpzp  jk;K 
sjprhukh   fhjwp@ 
     ? fz;qrhkpak; 
@rd;dpajp rhu”; rhU’; fpuhzp Fd;kk; 
 cd;dpa rafhrk; cl;fha;r;fy; ? Jd;dpna 
 nghf;Fk; tplnrhig  bghy;yhj ePhpHptpy; 
 tPf;f’; Tlhbjd tps;@ 
? fz;qrhkpak; 
 
@rd;dp tpl nrhigrhh; Fd;kk; ePupHpt[ 
 Jd;D’; fpuhzp Ruk; ngjp gd;Dgpu 
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 nkfk;  rakptuw;Ws; K:r;R tpf;fy; nky;tPf;k; 
MfpYaph; nghkwp@  
     ? fz;qrhkpak; 
@ cz;lhFk; ngjpjhd; cf;fpukha;f; fz;lhy; 
  cj;jknd FlYf;Fs; Jthu’; fz;L 
  ed;whf Fly; rt;t[j; jhgpjnk fz;L  
  epykhd Vuypy; jhd; rPf;fl;o bfhs;Sk; 
  gz;lhd ,uzKyh;e;J Flw;RU’;fp ehf;fhy; 
 gspr;brd;W kyge;jk; cz;lh kg;gh 
 rpz;lhd rpbyl;Lkr; rt;t[ mGfpg;nghdhy; 
 rpwg;g[lnd Rug;g[f; fz;L ,wg;ghd jhnd@ 
 
From the above verses , it is clear that severe diarrhea  leads to perforation and 
inflammation of the colon, Liver abscess, constipation and obstructions. Sometimes it 
may ends fatally. 
Prognosis:  
Kana Kazhichal is a curable  disease with proper medicine at proper time.If it is 
not treated with proper medicine, it may  leads to severe  abdominal discomfort, 
ulceration of colon causing passage of excessive amount of stools with mucus, Pulse 
appears weak, perspiration may seen.Eyes become sunken and dryness of tongue may 
present. Sometimes it may ends in fatal condition (Shanmugavelu 1988, kuppusamy 
mudhaliyar1987). 
 
Differential Diagnosis: 
khe;j fHpr;ry; 
 
@ the;jp gpuhe;jp  K:h;r;irajha; tha;e;J FuY”; rPzpj;J 
  fha;e;J nkdp btJbtJg;gha;f; iffhy; Fsph;e;J  typa[z;lhk; 
  nrh;e;J fHpt[ kye;jhDk; rPh;bfl;oUf;Fk; gytpjkha; 
  nghe;j khe;jf; fHpr;rypJ bghy;yhbjdnt g[fd;bwdnu@ 
        ? ghythflk; 
 
the;jp. kaf;fk;. K:h;r;ir. Fuy;fk;ky;. cly; fha;e;J btJbtJj;jy;. iffhy; 
Fsph;e;jpUj;jy;. typj;jy;. kyk;  nrh;e;jpUe;J gy tpjkhf fHpjy;. FHe;ij rhpahd 
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epiyapyhkw; gytpj Jd;gj;ij miljy; Mfpa FwpFz’;fs; fhqk; ,J kpf 
bfhoajhFk;/ 
 
Mkf;fHpr;ry; 
@cz;l ghbyjpbuLf;Fk; cly;gy KHf;f’; fhl;Lk; 
fz;Lnk uj;j”;r; RukpFe;j; jpUf;F nkdp 
fz;Lnrh; bkhHpa[e;j; jhH;e;J e;fhbyhL ifa[dPj;J 
tpz;oo yhk bkd;W tpsk;gpdh; Kdpth; jhnd @ 
 
cz;lgpd; ghy; vjpbuLj;J thahbyLf;Fk;. cly; mjpfkhf khWjyila[k;/  
clypy; bre;jPh; kpf Rz;Lk;/ Ruk; mjpfkhFk;/ Fuy; jhH;tila[k;/ if fhy; mirtw;W 
fplf;Fk;/ ,it Mkf;fHpr;rypd; Fz’;fs; MFk;/ 
tapw;Wist[:  
 
@te;jpLk; btJg;g[f;fha[k; tapWise;jpLjPd; bry;yhy; 
Juj;jpL Kw’;f bthl;lhJs ky’;fHpe;J nrhWk; 
bghUj;bjhyh’; fHYk; g[d;nghw; bghUf;bfhzh eLf’;Twy; 
bghUj;jpL’; fHpr;ry;rPjk; btWtapw;Wistpjhnk@ 
 
Increased body temperature, abdominal cramps, pain present in all major joints, 
shivering followed by frequent loose stools may also be observed in  the disease Vayittru 
Ulaivu. 
Kanakazhichal should also be differentiate from Vadha Kazhichal, Pitha 
Kazhichal, Kaba Kazhichal, Mukkutra Kazhichal and oozhi Noi. 
 
Maruthuvam(Treatment): 
 
@K:d;wpbyhd;w au;e;jij Kd;du; mwpe;J 
Ke;jpajid bahHpj;jpL kUe;jpL 
jzpa[k; nehapd; je;jpukpJnt 
ngzpf; fzpj;jpod; gpwtha; gpd; Fzk;@ 
In Siddha system of medicine, the principle of treatment is to  bringing back the 
vitiated thathus to their normal position. 
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Line of Treatment: 
1. In the disease Kana Kazhichal , the vitiated Kaba kutram and keelnokku kaal 
(Abanan) should be brought to their normal positions. 
2. Specific medicine for arresting the  stools with blood or mucous. 
3. A large number of medicines are stated in different literatures. Among them an 
economical and efficacious medicine is ‘Kana Kanakazhichal”.It is administered 
once a day. 
 
Diet Regimen: 
Cow’s butter milk, buffalo’s butter milk and goat’s milk are useful in Kana 
Kazhichal.  
 
@tPf;f knfhju Ks; tPWFd;kk; ghz;L gpj;je;j; 
jhf;F kUe;jpl;l jjprhunkhL ? Tf;Funy 
khwj; jphpnjh& ke;j kzw;whfk;nghk; 
tpwhtpd; nkhWf;F bka;@ 
     ? gjhh;j;j Fzrpe;jhkzp 
  
      @jhf’; fpuhzp fzf;fHpr;ry; fhkhiy 
      Mf’; Fil g[Gt[ kw;Wg;ngh ? nkhfkpy;yhj; 
      njthkph;j Kkh”; rPh; khdplh; jkf;F 
      K:thkUe;bjUik nkhu;@ 
     ? gjhh;j;j Fzrpe;jhkzp 
    @bts;shl;Lg;ghYf;F nktpa ew;wPgdkhe;j;  
     js;shL thj gpj;j”; rhe;jkhk; ?cs;spiug;g[r; 
    rPjkjprhu”; rpny&;k kWk; g[z;zhWk; 
    thj fpnyrKk; nghkha;e;J@ 
     ? gjhh;j;j Fzrpe;jhkzp 
 
   @ twF nrhWl ey;byz;bza;  itj;j ePh;r; nrhW nkhUk; 
     jukpF kpur thiH jh’;fpa fdpa[ ed;whk; 
     g[ukpF KRl;ilf;fPiu bghUe;jpa fwpa[dd;whk; 
     CukpF nkhU’;To a[z;oo Yist[ nghnk@ 
      ?guuhr nrfuk; ghy nuhfepjhdk; 
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gj;jpak; 
 
@ bew;bghhpiaj; jpz;why; beL’;jhfk; the;jp ke;jk;  
  kw;gpj;jk; thj kj K:h;;r;ir ? gw;gythk; 
  ngjpaUrpapit ngUyif tpl;blhHpa[k; 
  rhjpkl kapny rhw;W@ 
 
    ?Fzghlk; K:ypif tFg;g[ 
 
Riceflakes  is useful for to reduce thirst  nausea and vomiting in dysentery mainly 
useful in Kana Kazhichal if dehydration  present.   
 
fhuhzpf; fPiu fhl;Lg; gw’;fpapiy  
nguhk; bgUk; gaw;wpd; ngupiyfs;/ rPuhh; 
mfj;jpaU’; fj;jhpf;fha; MapiHna kPd;fs 
gifj;jjpUf;f ngjpjUk; ghh;@ 
    ? gjhh;j;j Fz rpe;jhkzp  
 
fhuhkzpf;fPiu. fhl;L gw’;fpapiy. bgUk;gaW ,iy mfj;jpf;fPiu. 
fj;jpupf;fha;. kPd;fs; Mfpa bghUl;fis ePf;f ntz;Lk;/ 
 
Line of Treatment: 
 In Siddha system of medicine, the principle of treatment bringing back the vitiated 
thathus to their normal position 
1. In the disease KanaKazhichal , the vitiated Kaba kutram and keelnokku kaal 
(Abanan) should be brought to their normal positions. 
2. Specific medicine to be  given  for arresting the loose stools with blood or 
mucous. 
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MODERN ASPECTS - BACILLARY DYSENTERY 
 
DYSENTERY 
Dysentery  is an acute inflammation of  the large intestine  characterized by 
diarrhoea with blood and mucus in the stools. 
Dysentery results from entero invasive  micro organisms like that bacteria ,fungi 
and protozoa penetrate through the mucosa and cause inflammation of intestinal wall . 
 
Bacteria; 
· Shigella (S. Sonnei, S. flexneri, S.boydi, S. dysentriae) 
· E.coli  (Enterotoxigenic, Enteropathogenic) 
· Salmonella 
· Staphylococcus 
· Camphylobacter 
Protozoa; 
· Entamoeba histalitica 
· Giardia lamblia etc 
Dysentery is mainly  Classified into two types;  
1) Bacillary dysentery  
2) Amoebic dysentery 
In this dissertration study, the author is discussing about bacillary dysentery. 
 
BACILLARY DYSENTERY: 
Bacillary dysentery is an acute infection of the bowel caused by the organisms 
belonging to the genus shigella. This disease is more common in children  than in adults. 
Shigella is nonmotile, gram negative bacilli belonging to the family 
Enterobacteriaceae and consists of four main pathogenic groups. 
                 1. S. dysenteriae (Group A) 
                 2. S. Flexneri (Group B) 
                 3. S. Boydii (Group C) 
                 4. S. Sonnei (Group D) 
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The genus is characterized by its ability to invade the intestinal epithelial cells and 
to produce highly potent toxins that irreversibly inhibit eukaryotic cells protein synthesis 
by a specific enzyme action. 
 
Epidemiology: 
Bacillary dysentery is endemic all over the world. It occurs in epidemic form 
wherever there is a crowded population with poor sanitation. Epidemics in civilian 
communities are associated with poverty. 
Infection with shigella occurs most often during summer and during rainy seasons 
in tropical climates. Both sexes are equally affected and in endemic among school going 
children in tropical countries. It is most common in poor hygienic places. 
S. dysenteriae occurred in south India in the years 1974-78 and in the eastern parts 
of India and Bangladesh in mid 1980. 
 
Mode of transmission:  
 The only sources of infection are human beings. The mode of transmission may be 
as follows; 
1. Direct through contaminated finger hands to mouth infection (Faeco oral route). 
2. Through contaminatd water and food or drinks. 
3. Through fomites such as door handles, water tapes, lavatory seats. 
4. Through flies which may transmit the infection as mechanical vectors. 
5. Though contaminated water when used to irrigate or wash vegetables. 
6. The spread is boosted by the low level of personal hygiene and environmental 
sanitation level. 
Pathogenesis: 
Transmission is  through fecal-oral and is remarkable for the small number of 
organisms that may cause disease (10 ingested organisms cause illness in 10% of 
volunteers, and 500 organisms cause disease in 50% of volunteers). Shigella bacteria 
invade the intestinal mucosal cells but do not usually go beyond the lamina propria. 
Dysentery is caused when the bacteria escape the epithelial cell phagolysosome, multiply 
within the cytoplasm, and destroy host cells. Shiga toxin causes hemorrhagic colitis and 
hemolytic-uremic syndrome by damaging endothelial cells in the microvasculature of the 
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colon and the glomeruli, respectively. In addition, chronic arthritis secondary to S. 
flexneri infection, called reactive arthritis, may be caused by a bacterial antigen; the 
occurrence of this syndrome is strongly linked to HLA-B27 genotype, but the 
immunologic basis of this reaction is not understood.                 
   Infection occurs by ingestion.The minimum infective dose is low as few as 
10,000 bacilli being capable of ini tiating the disease probably because they survive 
gastric acidity better than other enterobacteria.Their pathogenic mechanisms resemble 
those of Enteroinvasive E.coli. 
              Bactremia may occur on severe infections, particularly in malnourished children. 
 
Morphology: 
 In severe bacillary dysentery the colonic mucosa becomes hyperemic and 
edematous, enlargement of lymphoid follicles creates small projection nodules.Within the 
course of 24 hours, fibro suppurative exudates first patchily then diffusely covers the 
mucosa and produces a dirty grey yellow pseudo membrane. 
The inflammatory reaction within the intestinal mucosa builds up the mucosa 
becomes soft and friable and irregular superficial ulcerations appear. 
Histologically, there is predominantly mononuclear leukocytic infiltrate within the 
lamina propria ,but the surfaces of the ulcers are covered with an acute, suppurative, 
neutropilic reaction accompanied by congestion, marked edema, fibrin deposition  and 
thrombosis of small vessels. 
 
Incubation period:  
          The incubation period is generally between 2-7 days. 
 
Clinical features: 
After ingestion of shigella there is an incubation period of several days before 
symptoms. Characteristically severe abdominal pain, fever, anorexia, passing mucoid 
consistency of loose stools occurs. 
The stools may be watery or mucoid large volume initially evolving into frequent 
bloody mucous stools.Physical examination may show abdominal distension and 
tenderness, hyperactive bowel sounds and tender rectum on digital examination.Chronic 
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diarrhea is uncommon except in malnourished infants.Only about 10% patients have 
diarrhea persisting for more than 10 days. 
Neurological findings are among the most common extra intestinal manifestation 
of bacillary dysentery occurring in 40% of hospitalized infected children. 
        They are, 
· Convulsion 
· Lethargy 
· Headache 
· Confusion 
· Nuchal rigidity 
· Hallucination 
The causes of neurological findings are not known. Hypocalcemia and 
hyponatraemia may be associated with seizures in a small number of patients. Most 
important complication is dehydration with its attention risk of renal failure and death. 
 
Symptoms and Complications:  
 The main symptom of dysentery is frequent near-liquid diarrhea flecked with 
blood, mucus, or pus. Other symptoms include: 
· Sudden onset of  fever and chills 
· Abdominal pain 
· Cramps and bloating 
· Flatulence (passing gas) 
· Urgency to pass stool 
· Feeling of incomplete emptying 
· Loss of appetite  
· Weight loss 
· Headache 
· Fatigue 
· Vomiting 
Other symptoms may be intermittent and may include recurring low fevers, 
abdominal cramps, increased gas, and milder form of  diarrhea. The patient may  feel 
weak and anemic, or lose weight over a prolonged period (emaciation). 
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Mild cases of bacillary dysentery may last 4 to 8 days, while severe cases may last 
3 to 6 weeks. Amoebiasis usually lasts about 2 weeks. 
Bacillary dysentery symptoms begin within 2 to 10 days of infection. In children, 
the illness starts with fever, nausea, vomiting, abdominal cramps, and dysentery. Episodes 
of diarrhea may increase to as much as once an hour with blood or mucus  in the child's 
stool. Vomiting may result in rapid and severe dehydration, which may lead to shock and 
death if not treated. Signs of dehydration include an extremely dry mouth, sunken eyes, 
and poor skin tone. Children and infants will be thirsty, restless, irritable, and possibly 
lethargic. Children may also have sunken eyes and may not be able to produce tears or 
urine, the latter appearing very dark and concentrated. 
 
Diagnosis: 
Essentials of diagnosis: 
· Abdominal pain with loose mucoid stools 
· Fever 
· Peripheral blood leucocytosis 
· Stool culture 
 
 Prevention: 
As bacillary dysentery is exclusively human infection transmitted by feceo oral 
route, control consists essentially in improving environmental sanitation.Health education 
with an emphysis on washing hands with soap after each defecation is important. 
Decontamination of water supplies, use of sanitary latrines, protection of food 
preparation and its storage can all reduce the primary and secondary transmission of 
shigella. 
Breast feeding decreses the risk of symptomatic shigellosis and its severity in 
infants who acquire infection despite breast feeding. 
ü Eradication of vectors such as houseflies. Hygienic practices such as keeping food 
covered filtration and boiling water etc. 
ü Since chlorination of water in effective iodine realizing tablets, Globaline tablets 
are convenient and effective. 
ü Avoiding consumption of raw vegetables can reduce the incidence of amoebiasis. 
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ü Those cooking for large number of people must periodically undergo stool 
examinations for detecting asymptomatic cyst passers who are the reservoirs of 
infection. 
ü Proper sanitary disposal of human excreta. 
ü Maintaining good personal hygiene like hand washing with soap after 
defacation.These factors are effective in the prevention of disease 
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LITERATURE  REVIEW - INGREDIENTS OF THE STUDY DRUG 
 
INGREDIENTS OF MOOKURATTAI ENNAI (Internal Medince) 
Ø K:f;Ful;il  
Ø rhuiz 
Ø Klf;fw;whd; 
Ø Kj;bjUf;fd; brtp 
Ø XhpjH; jhkiu 
Ø brg;g[ beU”;rpy; 
Ø kapypwfpd; rhk;gy; 
Ø Mkzf;F bea;  
 
bray;Kiw 
 K:f;Ful;il. Rhuiz, Klf;fw;whd;. Kj;bjUf;fd; brtp. XhpjH;; jhkiu, brg;g[ 
beU”;rpy;. Mfpa MW bghUl;fspd; rhWk; tiff;F xU go (1/3 ypl;) tPjbkLj;J. 
mj;Jld; xU go (1/3 ypl;) Mkzf;F bea; nrh;j;J xU kz; rl;oapy; Cw;wp ,tw;Wld; 
xU gyk; (40 fpuhk;) kapypwFr; rhk;gy; nrh;j;Jf; fha;r;rpf; fhiyapy; kl;L;k; xU 
cr;rpf;fuz;oast[ neha; td;ikf;Fj; jf;f ehsst[ bfhLj;J te;jhy; fHp fz’;fspd; 
tiffs; vy;yhk; jPUk;/ 
mst[   :  cr;rpf;fuz;o mst[ (1/6ml) 
Ma[l;fhyk;  :  1 Mz;L 
Mjhu Ehy;  :  ghythflk;  
Mrphpah; :  kU/bghd;/ FU rpnuhd;kzp 
gjpg;ghrphpah;fs; :  kU/f/r/KUnfr Kjypahh; 
                           kU/bghd;/ FU rpnuhd;kzp 
gjpg;g[    : 1933 
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        Borrhaeavia diffusa  (Mookurattai)                    Trianthema decandra (Saranai) 
 
               
          
 
 
 
 
 
 
 
 
 
 
Cardiospermum calicabum                      Elytraria acants                          
            (Mudakatran)              (Mutherukkan sevi) 
 
     
   
  
 
       
   
   
          
       
                 
    
                  Ionidium suffruticosum                    Indigoferra ennaphylla 
              (Orithal thamarai)                                  (Seppu nerunjil)           
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Ricinus communis                                       Peacock feather  
             (Amanakku ennai)                                               (Mayilaragu sambal)       
 
1/K:f;Ful;il(Borrhaevia Diffusa) 
 ntWbgah; 
 g[l;gfk;. K:f;Fwl;il. ,uj;jg[l;gpfh 
  
Scientific Classification 
 Kingdom  -  Plantae 
 Division -   Angiosperms 
 Order   -   Caryophyllale 
 Family   -   Nyctaginaceae 
 Genus    -   Boerhavia 
 Specices  -   B.Diffusa  
Organoleptic Characters:  
Taste  - Kaippu 
Potency - Veppam (heat) 
Pirivu  - Kaippu (Pungent) 
Action:  
Ø Expectorant 
Ø Diuretic 
Ø Laxtive 
Ø Refrigerant 
Ø Anthelmintic 
Ø Emetic 
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bghJFzk; 
  @rPj kfw;We; jpdtlf;F’; fhe;jpjUk; 
   thj tpidia kof;F’;fhz;? ngjp  
   bfhLf;Fkij cz;lhf;fhw; nfhksnk! gpj;jk; 
  mLf;Fnk K:f;Ful;il aha;@ 
 
Chemical Constitunents: 
Isoflavonoids knows as rotenioids, flavonoids, flavonoid glycosides, xamthones, 
pusine Nucleoside, lignans, ecdysteriods and steroids. 
 
Mechanical uses: 
Ø Reduces Swelling – Anti inflammatory 
Ø Useful in anemia, early stage of liver disorders 
Ø Useful in cardiac disorders 
Ø Excellent diuretic – High blood pressure requiring diuretic action,   
Ø Relieves sputum 
Ø Improves digestion strength  
 
Published Research Paper: 
 Borrhaevia diffuse: A review on its phyto chemical and pharmacological  profile 
shows Immunomodulations, Hepatoprotective,Antifibrinolysis, anticancer activity, 
antidiabetic activity, anti inflammation and diuretics..  Antimicrolial activity ( against  
E.Coli, Bacillus subtilis, staphyococus and  salmonella typhi) Anticonvulsant activity. 
Antiproiferative, Antiesrtogenic activity. 
 
2.rhuiz: (Trianthema decandea) 
 ntWbgah;: 
 rhl;luiz. rhWz;iz. rhWntis. bts;isr; rhuiz. bts;isr; rhuil. 
rj;jpr;rhuiz. rj;jpr;rhl;luiz. tpUr;rpfk; 
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Scientific classification: 
 Kingdom - Plantae 
 Division   -   Angiosperms 
 Order      -   ficoideae 
 Family     -   Aizoaceae 
 Genus   -   Trionthema 
  Species -   decandra   
Organoleptic Characters: 
 Taste  -  Kaippu 
 Potency  - Veppam (heat) 
 Pirivu     -   Kaarpu (purgent) 
Action:- 
Ø Expectorant 
Ø Laxative 
Ø Diuretic 
 
bghJFzk; 
  @rPj”; rynjhle; njky;j Gk;g[ Fd;kk; 
   thj”; rpWrpu’; td;nkfk; ? Xjhpa 
   fhrKjy; nehbay;yh’; fhd;rh wilf;fpH’;fhy; 
   ehrKW bkd;nw etpy;@ 
 
Chemical Constituents: 
  Ecdysterone, 3 Acetylaleusitotic acid, 5,2’ – dihydeoxy – 7 – methoxy – 6,8 
Dimethyl flavones, leptorumol, 3,4 – dimethoxy cinnamic acid, 5 – hydeoxyl 2-
methoxybenzaldehyde, P- methoxybenzonic acid, beta cycamin. 
 
Medicinal  Uses:- 
Useful in hepatitis, authuma, suppression of the menses, ground up with milk and 
given internally consider specific in orchitis.  Decoction of root bark is apesient, Juice of 
leaves dropped into the nostrils to relieve one side headache. 
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Research Studies:- 
 Trianthema decandra, A review on its Phytochemical and Phyamacological profile 
shows anti inflammatory, wound healing, antihyperglycemia, hepatoprotective, 
antioxidant, - international Journal of Engineering science and Technology. 
 
3/Klf;fw;whd; (Cardiospermum Calicacabum) 
 ntWbgah; ? Klh;Fw;whd;.  Klf;fWj;jhd; 
 
Scientific Classification:- 
 Kingdom - Plantae 
 Division   -   Angiosperms 
 Order      -   sapindales 
 Family     -   sapindaceae 
 Genus   -   cardiospermum 
  Species -   C.Halicacabum 
Organoleptic character: 
Taste   - Bitter 
Potency - karppu 
Pirivu  - veppam 
Action: 
Ø Diuretic 
Ø Laxative 
Ø Stomachic 
Ø Rubefacient 
Ø Antivatha 
Ø Nutritive 
bghJ Fzk; 
  Niyg; gpog;g[ brhwp rpu’;F td;fug;ghd; 
  fhiyj; bjhLtha;t[‘; fd;kyKk; ? rhyf; 
  flf;fj;jh ndhotpL’;f fhrpdpia tpl;L 
  Klf;fw;whd; wd;id bkhHp 
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Research Studies:  
Antipyretic activity   Ashavv– Indian J EXP  Biol 1999 April 37(4), 411-4 ,    
  (Pubmed indexed ) 
Anti-diarrhoeal   Chandraprakash,kuppast -  Interenational Journal of  
Pharmacy pharmacutial science ISSN 0974-1491. 
 Antibacterial   R.Vinoth R.Manivasagaperumal - Inf J.Res. Biol -2012 
Anti-diarrheal    (1) S.Sasidharani, (2) Lylatha Z Zuraini (3) S.Suryani  
Indian Journal of – medknow   Pharamology 
Indian Journal of – medknow   Pharamology 
 
4. XhpjH; jhkiu (Ionidium Suffrutiocosum)  
ntWbgah;? Nhpafhe;jp. ,uj;jg[U&; 
 
Organoleptic Characters:  
Taste  -  Enippu 
 Potency  - Thatpam 
 Pirivu     -   Enippu 
Action: 
Ø Nutritive 
Ø Aphrodisiac 
 
bghJ Fzk; 
  jhJita[z;lhf;Fe; jdpnkfj;ijj; bjhiyf;Fk; 
  Mjuth nkdpf; fH;FjU”; ? rPjk;nghk; 
  rPhpjH;j; jhkiuthH; bra;a kltdnk> 
  XhpjH;j; jhkiuia a[z; 
 
Chemical Constituent: 
Ø Tannins  
Ø Flavonoids 
Ø Terpenoids 
Ø Saponins 
Ø Cardiac glycosides 
Ø Amino acids 
Ø Alkaloid 
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Medicinal uses: 
Orithal thamarai choornam is given in the dose of 2 to 4 grams twice  a day with  
milk  for megham diseases or gonorrhoeal diseases in ladies,leukorrhoeaa, increases  
sexual  power or libido,improve the quality of  semen. In women, during parturition 
enchances milk secretion.   
The samoolam is crushed squeezed well in water and  this extract  is used to wash 
the eyes in the conditions like itching in the eyes, pain, conjunctivitis etc. 
This herb is a Kayakalpam  and regular  intake of this acts as a tonic  and  relieves 
ulcer  and  headache when  externally applied. 
An infusion or decoction of the roots  is given for  urinary  infection. 
  
5. brg;g[ beU”;rpy:    ( Indigofera enneaphylla) 
Synonyms:   Bremontiera,Vaughania  
  
Scientific classification: 
Kingdom :  plantae 
Order  :  Fabales  
Family  :  Fafaceae 
Subfamily : Faboidea 
Genus  : Indigofera 
Species :  I.enneaphylla       
 
Organoleptic character: 
Taste  :  enippu 
Potency : Thatpam. 
Pirivu  :  Enippu 
 
 Medicinal  Uses : 
It is used for the treatment of numerous ailments ranging from hemorrhoids to 
scorpion bites. 
Protective  effect against carbon tetrachloride induced hepatotoxcity. 
It is used in the treatment for ovarian  and stomach cancer. 
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Chemical constituents: 
Ø Indican 
Ø Glucoside 
Ø Crude proteins  
Ø Calcium 
Ø Research article: 
Indian Journel of pharmacology by Hemalatha 2001- Antidiarrhoral  activity. 
 
6/ Kj;bjUf;fd; brtp : (Asarum europium)  
ntWbgah; : epyf;flk;g[. Faf;fhyk;. Fafhak;. nfhfdk; 
 
Scientific classification: 
Kingdom :  plantae 
Order  : Angiosperm 
Family  :  Aristalochiaceae 
Genus  :  Asarum 
Species :  A.europaeum 
Organoleptic character: 
Taste  :  Karppu 
Potency :  Veppam 
Pirivu  :  Karppu 
Action: 
Ø Diuretic 
Ø Carminative.                         
Ø Emetic  
 
Chemical Constituent: 
Ø Volatile oil 
Ø Tannic acid 
Ø Resin 
Ø Gluten 
Ø Asartin 
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Medicinal uses: 
It cures jaundice, headache, tooth ache and neurological disorders 
Its cures respiratory problems,indigestion,bronchitis.. 
 
7/ kapypwF : Peacock feather ( Pavo cristatus) 
 
Kingdom - Animalla 
Class  -  Aves 
Order  -   Galliformes 
Family  - Phasianidae 
Subfamily - Phasianinae 
Genus  - Pavo 
Chemical Constituent: 
Ø Copper 
Ø Iron  
Ø Manganese 
Ø Zinc  
Ø Melanin pigment 
Action: 
Ø Antiemetic 
Ø Mild Antitussive 
Ø Mild Bronchodilatory 
Ø Hiccup suppressant. 
Medicinal uses: 
It cures   nausea, voiting, hiccup,  and respiratory problems. 
Apinch of the powder  of the peacock feather if taken with honey to remove 
poison from the body. 
8.Mkzf;F bea; (Ricinus Communis) 
 ntWbgah;? Vuz;lk;. rpj;juk;. jyU:gk 
 
Scientific Classification:- 
 Kingdom  -  Plantae 
 Division   -   Angiosperms 
 Order      -   malpighiales 
 Family     -   Euphorbiaceae 
 Genus   -   Ricinus 
  Species -   Ricinus communis 
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Organoleptic Characters:  
 Taste  -  Kaippu 
 Potency  - veppam  
 Pirivu     -   Karppu 
Action 
Ø Anti- inflammatory  
Ø Laxative 
Ø Emollient 
Ø Anti- Bacterial  
bghJ Fzk;  
                             @nauz;lj;Jbea; bad;gJ lw;bfhL 
   rPuz;lj;jzp bra;jpU eprnk@ 
 
@Mkzf; bfz;bza; jd;id azpepy kwpaf; nfz;kpd; 
g{kzr; re;JnjhWk; bghUe;jpa thjk; nghf;Fk; 
jPke;je; jhDk; nghf;Fe; jpfH;t[ld; tpiut[ Kz;lhk; 
jPkdf; Flypy; thj”; nrh;Fl nyw;wk; nghnk@ 
 
Chemical Constituent: 
Ø Ricinoleic Acid 
Ø Oleic acid 
Ø Stearic acid 
Ø Palmitic acid 
Ø linoleic acid 
Ø dihydroxy stearic acid 
Mecditional Uses:- 
Ø Castor oil (Ricinus communis) raises body heat and acts as a purgative.   
Ø It cures gastritis and gunmam, if taken internally.  
Ø It gives gold complexion to the body and improves spermatogenesis.   
Ø It recitifies the intestinal disorders.  
Ø It removes burning sensation in the five sense organs, if taken  internally.  
Ø Castor oil gives many soothing effect to the body 
 
  
 
 
 
MATERIAL AND 
METHODS  
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MATERIALS AND METHODS 
Kanakazhichal is one of   the  common  GIT disorder  in children. In our NIS OPD, a 
3-5% of cases are approaching Kuzhandhai Maruthuvam department daily with the 
Symptoms of Kanakazhichal .Hence  it was proposed to study about  the disease. . A 
Protocol   was prepared and submitted be fore IEC o f National Institute of Siddha. The 
IEC , approval No:NIS/IEC/9/2014-15/19-26-08-2015. The trial registred in Clinical trial 
Registry of India with Reg .No.CTRI/2017/02/007952. After obtaining approval from  the 
committee, the clinical study on Kanakazhichal (Bacillary Dysentery ) in  children and the 
drug  of choice  Mookurattai ennai was   carried out as per the protocol.. 
40 cases were selected from the OPD of KuzhandhaiMaruthuvam Department, 
National Institute of Siddha. They were treated with the trial drug with Mookurattai ennai 
and observed for prognosis clinically. 
 
PRECLINICAL STUDIES:  
PHYSICO CHEMICAL ANALYSIS OF MOOKURATTAI ENNAI 
The physicochemical analysis of the test drug MOOKURATTAI ENNAI was 
carried out as per WHO guidelines (Anonymous 1998). The test procedures were done at 
Sathyabama university , Chennai. Since the form of the drug is in powder  the parameters 
such as) Loss on Drying at 105’c, Total ash, Acid unsoluble ash , Water soluble 
Extractive Alcohol Soluble Extrative, PH was done using Quality control procedures 
mentioned in AYUSH  protocol for testing guidelines. 
 
Percentage Loss on Drying 
10gm of test drug (weight equivalent to oil) was accurately weighed in 
evaporating dish. The sample was dried at 105oC for 5 hours and then weighed. 
 
Determination of Total Ash 
3 g of test drug (weight equivalent to oil) was accurately weighed in silica dish 
and incinerated at the furnace a temperature 400 ºC until it turns white in color which 
indicates absence of carbon. Percentage of total ash will be calculated with reference to 
the weight of air-dried drug. 
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Determination of pH 
Sample being oily in nature the direct litmus evaluation method was adopted to 
check the pH of the sample.  
 
Determination of Iodine value  
About 20 gm of oil was transferred into Iodine flask. To which 10 ml of 
chloroform  was added and warmed slightly and cooled for 10 minutes. Followed by this 
about 25 ml of Wiji’s solution was added in the same flask and shaken well. The flask 
was allowed to stand for 30 mins and refrigerated for a hour. About 10 ml of KI solution 
was added to this and titrated against 0.1 N Sodium thiosulphate solutions until the 
appearance of yellow colour. 1 ml of starch indicator was added and again titrated against 
the sodium thiosulphate solution from the burette. Disappearance of blue colour indicates 
end point. Repeat the above procedure without taking sample and note the corresponding 
reading for blank titration. 
 
Determination of saponification value  
About 2 gm (weight equivalent to oil) of test sample was transferred into the 
round bottomed flask. To this about 20 ml of 0.5 N alcoholic KOH solutions was added to 
the round bottomed flask. Repeatthe same procedure without taking the sample for blank 
titration . Reflux both sample and blank round bottomed flasks for 1 hour. After reflux, 
allow both the round bottomed flasks to cool. Titrate the samples using 0.5 N HCl with 
phenolphthalein indicator. The disappearance of pink indicates the end point.  
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PHYTOCHEMICAL ANALYSIS 
 
Sample Preparation 
Mookuattaioil (MO) was extracted with ethanol and the extract was subjected to the 
following analysis 
1. Test for alkaloids: 
Mayer's Test: To the extract, 2ml of mayer's reagent was added, a dull 
white precipitate revealed the presence of alkaloids. 
2. Test for coumarins:  
To 1 ml of extract, 1 ml of 10% sodium hydroxide was added. The 
presence of coumarins is  indicated by the formation of yellow color. 
3. Test for saponins:  
To 1 ml of the extract, 5 ml of water was added and the tube was shaken 
vigorously. Copious lather formation indicates the presence of Saponins. 
4. Test for tannins:  
To the extract, ferric chloride was added, formation of a dark blue or 
greenish black color showed the presence of tannins. 
5. Test for glycosides- Borntrager’s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on 
a water bath, filtered and the hydrolysate is subjected to the following tests. To 2 
ml of filtered hydrolysate, 3 ml of choloroform is added and shaken, choloroform 
layer is separated and 10% ammomia solution is added to it. Pink colour indicates 
presence of glycosides. 
6. Test for flavonoids: 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were 
been added followed by addition of few drops of conc. Sulfuric acid. Appearance 
of yellow color indicates the presence of Flavonoids. 
7. Test for phenols: 
Lead acetate test: The extract was taken; 3 ml of 10% lead acetate 
solution was added.  A bulky white precipitate indicated the presence of phenolic 
compounds. 
8. Test for steroids: 
To the test solution 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube was turns 
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into red and sulphuric acid layer showed yellow with green fluorescence. It 
showed the presence of steroids. 
9. Test for Quinones:  
The extracts were treated separately with Alc. KOH solution. Appearance 
of colors ranging from red to blue indicates the presence of Quinones. 
10. Test for Cyanins 
A. Aanthocyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and 
heated for 5 min at 100 C. Formation of bluish green colour indicates the 
presence of anthocyanin. 
B. Betacyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and 
heated for 5 min at 100 C.  Formation of yellow colour indicates the presence 
of betacyanin. 
11. Test for Carbohydrates - Benedict’s test 
To 0.5 ml of test drug about 0.5 ml of Benedic’s reagent is added. The 
mixture is heated on a boiling water bath for 2 minutes. A characteristic coloured 
precipitate indicates the presence of sugar. 
12. Test for terpenoids: 
Salkowski test: 5ml of extract was mixed in 2ml of chloroform, and 
concentrated sulphuric acid was carefully added to form a layer.  A reddish brown 
colouration of the interface indicates the presence of terpenoids. 
 
 TLC ANALYSIS 
Test sample MO was subjected to thin layer chromatography (TLC) as per 
conventional one dimensional ascending method using silica gel 60F254, 7X6 cm 
(Merck) were cut with ordinary household scissors. Plate markings were made with soft 
pencil. Micro pipette were used to spot the sample for TLC applied sample volume 10-
micro liter by using pipette at distance of 1 cm at 5 tracks. In the twin trough chamber 
with different solvent system A. Ethyl acetate:Methanol:Water (7.5:1.5:1) B. chloroform: 
Methanol: Water (7:3:4). After the run plates are dried and was observed using visible 
light Short-wave UV light 254nm and light long-wave UV light 365 nm 
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Solvent System Ethyl acetate: Methanol: Water (7.5:1.5:1) 
 
            Visible                  Short UV                      Long UV 
 
 
 
 
 
 
 
 
 
Solvent System B. chloroform: Methanol: Water (7:3:4) 
         Visible                      Short UV             Long UV 
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High Performance Thin Layer Chromatography Analysis 
 
HPTLC method is a modern sophisticated and automated separation technique 
derived from TLC. Pre-coated HPTLC graded plates and auto sampler was used to 
achieve precision, sensitive, significant separation both qualitatively and quantitatively. 
High performance thin layer chromatography (HPTLC) is a valuable quality assessment 
tool for the evaluation of botanical materials efficiently and cost effectively. HPTLC 
method offers high degree of selectivity, sensitivity and rapidity combined with single-
step sample preparation. In addition it is a reliable method for the quantitation of nano 
grams level of samples. Thus this method can be conveniently adopted for routine quality 
control analysis. It provides chromatographic fingerprint of phytochemicals which is 
suitable for confirming the identity and purity of medicinal plant raw materials.  
 
Chromatogram Development 
It was carried out in CAMAG Twin Trough chambers. Sample elution was carried 
out according to the adsorption capability of the component to be analysed. After elution, 
plates were taken out of the chamber and dried. 
 
Scanning 
Plates were scanned under UV at 366nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print was 
developed for the detection of phytoconstituents present in each extract and Rf values 
were tabulated.  
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HPTLC Chromatographic condition  
TLC Chromatogram of MO 
 
 
 
 
 
 
 
 
 
 
 
 
ANTI- MICROBIAL ACTIVITY OF MOOKURATTAI ENNAI 
Disc-diffusion method:  
 
The antibacterial activities of the sample MO were carried out by disc diffusion 
method.  The concentrations of the test compounds were used at the concentration of 500, 
1000 and 200 µg. The target microorganisms were cultured in Mueller–Hinton broth 
(MHB). After 24 h the suspensions were adjusted to standard sub culture dilution. The 
Petri dishes containing Muller Hinton Agar (MHA) medium were cultured with diluted 
bacterial strain. Disc made of Whatman No.1, diameter 6 mm was pre-sterilized and was 
maintained in aseptic chamber. Each concentration was injected to the sterile disc papers. 
Then the prepared discs were placed on the culture medium. Standard drug Ciprofloxacin 
(5µg) was used as a positive reference standard to determine the sensitivity of each 
microbial species tested. Then the inoculated plates were incubated at 37o C for 24 h . The 
diameter of the clear zone around the disc was measured and expressed in millimeters as 
its anti-microbial property. The results were depicted 
 
 GCMS- Analysis Report Mookurattai ennai 
 GC-MS Plays a key role in the analysis of unknown components of plant origin. 
GC-MS ionizes compound and measures their mass numbers. Ionization method includes 
EI (Electron Ionization). The EI method produces ions by colliding thermal electrons 
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emitted from a filament with sample gas molecules. This method provides high stability 
in ionization and obtained mass spectra show good reproducibility. The EI method 
provides good result for quantitative analysis as well. Quantitative analysis with GC-MS, 
in which only ions specific to the compounds are measured, is highly selective method 
without interfering components. Gas chromatography Technique involves the separation 
of volatile components in a test sample using suitable capillary column coated with polar 
or non-polar or intermediate polar chemicals. Elite-1 column (100% Dimethyl 
polysiloxane) is a non-polar column used for analysis of phyto-components. Elite -5 
column (5% phenyl and 95% methyl polysiloxane) is an intermediate column and also 
used for the estimation of Phytochemical. An inert gas such as hydrogen or nitrogen or 
helium is used as a carrier gas .The compounds of test sample is evaporated in the 
injection port of the GC equipment and segregated in the column by absorption and 
adsorption technique with suitable GC programme. 
 
BIOCHEMICAL ANALYSIS 
Biochemical Analysis of Mookurattai ennai was done at the Biochemistry lab at 
National Institute of Siddha, Chennai by the method of Kolkate. 
 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 
100ml volumetric flask and made up to 100ml with distilled water. This preparation is 
used for the qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
 
Procedure: 
Test for Silicate 
A 2ml of the sample was shaken well with distilled water. 
 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
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Ash Test: 
            A filter paper was soaked into a mixture of extract and dil. cobalt nitrate solution 
and introduced into the Bunsen flame and ignited 
 
Test for Acid Radicals 
Test for Sulphate: 
2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% 
dil ammonium oxalate solution 
 Test for chloride: 
2ml of the above prepared extracts was added with 2ml of dil.HCl is added until 
the effervescence ceases off. 
Test for Phosphate: 
2ml of the extract were treated with 2ml of dil. ammonium molybdate solution 
and 2ml of con. HNo3. 
Test for carbonate: 
2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
Test for Nitrate: 
1gm of the extract was heated with copper turning and concentrated H2So4 and 
viewed the test tube vertically down. 
 
Test for Basic radicals 
Test for lead: 
2ml of the extract was added with 2ml of dil.  potassium iodine solution. 
Test for copper: 
One pinch (25mg) of extract was made into paste with con. HCl in a watch glass 
and introduced into the non-luminuous part of the flame. 
Test for Aluminium: 
           To the 2ml of extract dil. sodium hydroxide was added in 5 drops to excess. 
Test for Iron:  
           a. To the 2ml of extract add 2ml of dil. ammonium solution  
           b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is 
added. 
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Test for Zinc: 
To 2ml of the extract dil. sodium hydroxide solution was added in 5 drops to 
excess and dil. ammonium chloride is added.  
Test for Calcium: 
To 2ml of the extract was added with 2ml of 4% dil. ammonium oxalate solution 
Test for Magnesium: 
To 2ml of extract dil. sodium hydroxide solution was added in drops to excess. 
Test for Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and excess of dil .sodium hydroxide 
solution are added. 
Test for Potassium: 
A pinch (25mg) of extract was treated of with 2ml of dil. sodium nitrite solution 
and then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic acid. 
 Test for Sodium: 
2 pinches (50mg) of the extract is made into paste by using HCl  and introduced 
into the blue flame of Bunsen burner. 
Test for Mercury: 
         2ml of the extract was treated with 2ml of dil. sodium hydroxide solution. 
Test for Arsenic: 
          2ml of the extract was treated with 2ml of dil. sodium hydroxide solution 
 
Miscellaneous 
Test for Starch: 
2ml of extract was treated with weak dil. Iodine solution. 
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil 
for 2 minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The 
colour changes are noted. 
Test for the Alkaloids: 
      a) 2ml of the extract was treated with 2ml of dil. potassium Iodide solution. 
      b) 2ml of the extract was treated with 2ml of dil. picric acid. 
     c) 2ml of the extract was treated with 2ml of dil. phosphotungstic acid. 
Test for Tannic Acid: 
 2ml of extract was treated with 2ml of dil.ferric chloride solution. 
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Test for Unsaturated Compound: 
To the 2ml of extract 2ml of dil. Potassium permanganate solution is added. 
Test for AminoAcid: 
2 drops of the extract was placed on a filter paper and dried well. 20ml of Burette 
reagent is added. 
Test for Type of Compound: 
2ml of the extract was treated with 2 ml of dil. ferric chloride solution. 
 
CLINICAL STUDIES 
AIM  
a)  Primary aim : 
To find out the  efficacy of Mookurattai ennai in the treatment of Kana 
Kazhichal in children. 
b) Secondary aim: 
To find out the side effects of the drug, if any 
 
Population and Sample:  
The population consists of paediatric patients attending the OPD of      Ayothidoss 
Pandithar Hospital, National Institute of Siddha, Chennai-47.  
The sample consists of 5 - 12 years age group fulfilling all the inclusion criteria 
and the exclusion criteria.  
 
Sample size :  40 Patients  
Study place :  OPD  of Ayothidosspandithar hospital,  
National Institute of Siddha, Tambaram sanatorium, Chennai – 46. 
Inclusion criteria: 
· Age 5 to12  years 
· Sex: Both male and female children. 
·  Children with minimum 3  clinical symptoms such as   
·   Increased frequency of stool with mucous at least   3 to 4 times per day. 
·   Fever 
·   Patients with history of abdominal pain. 
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Exclusion criteria:   
· High-grade fever 
· Signs of severe dehydration. 
· Extra intestinal complication. 
· Patient’s with any other serious illness. 
  Chronic diarrhea / malabsorption. 
 
Withdrawl criteria:  
· Exacerbation of symptoms 
· Intolerance to the drug & development of adverse reactions during drug trial. 
· Poor patient compliance & defaulters. 
             Patient turned unwilling to continue in the course of clinical trial. 
 
Study Enrollment: 
·  In this study, patients reporting at the NIS OPD with five or more clinical 
symptoms of blood with mucous in the stools, fever with chills, abdominal pain, 
and rumbling noise in the intestine. It will be examined clinically for enrolling in 
this study based on the inclusion and exclusion criteria.  
· The patients who are to be enrolled would be informed about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to them. 
· After ascertaining the patients’ willingness, informed consent (Form II) would be 
obtained in writing from their parents in the consent form. 
· All these patients will be given investigator phone number to report easily if any 
complications arise. 
· Complete clinical history, complaints and duration, examination findings-- all will 
be recorded in the prescribed Case sheet proforma and clinical assessment forms 
separately. Screening Form- I will be filled up. Form III,   Form –IV and Form –V 
will be used for recording the patient’s history, clinical examination of symptoms 
and signs and laboratory investigations respectively. 
· Patient will be advised to take the trial drug and appropriate dietary advice  would 
be given by dietary form according to the patients’ perfect understanding 
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Conduct of the Study: 
The trial drug “Mookurattai ennai” is given for 3 days. For OP patients before 
and after treatment the clinical assessment will be done and prognosis is noted on 4th day.   
For IP patients the drug is provided and prognosis is noted and clinical assessment will be 
done on 1st day itself.  
 
Data Managment: 
After enrolling the patient in the study, a separate file for each patient will be 
opened and all forms will be filed in the file. When study patient visits OPD during the 
study period, the respective patient file will be taken and necessary recordings will be 
made at the assessment form or other suitable form.The screening forms will be filed 
separately. 
The Data recordings will be monitored for completion and adverse event by HOD 
and data logical recording and completeness will be monitored by statistician (SRO-
Statistics)). All forms will be further scrutinized in presence of Investigator by (SRO- 
Statistics) for logical errors and incompleteness of data before entering onto computer to 
avoid any bias. No modification in the results is permitted for unbiased report. 
Any missed data found in during the study, it will be collected from the patient, 
but the time related data will not be recorded retrospectively All collected data will be 
entered using MS access software onto computer. 
 
CLINICAL ASSESSMENT (By modified Vesikari Scoring System): 
The Clinical Assessment  will be done by using modified Vesikari Scoring System shown 
in the following  system 
Nature of 
DYSENTERY 
Scoring 
1 2 3 
Maximum 
number of stools 
per day 
1-3 4-5 >6 
Dysentery 
duration ( Days) 
1-3 4-5 >6 
Stools consistency 
Semisolid 
stools 
without 
mucus 
Loose watery stools 
with mucus without 
pain. 
Loose watery stools 
with mucus 
associated with pain. 
Abdominal pain No pain Vague pain  Moderate pain to severe pain. 
Temperature  37.1.38.4 38.5.38.9 >39.0 
 
 
50 
 
Advese Effect/Serious Effect Management: 
If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and proper management will be given in OPD of National 
institute of siddha and the same will be reported to regional pharmacovigilance center. 
 
Ethical Issues: 
1. No other external or internal medicines will be used.  
2. The data collected from the patient’s informant will be recorded. The patient’s 
informant will be informed about the diagnosis, treatment and follow-up.  
3. After the consent of the patient’s informant (through consent form), patient will be 
enrolled in the study.  
4. Informed consent will be obtained from the patient’s informant explaining in the 
understandable language to the patient’s informant. 
5. Treatment would be provided free of cost. 
6. In conditions of treatment faliure, adverse reactions, patients will be given             
alternative treatment at the National Institute of Siddha with full care. 
 
Data Collection Forms:- 
Form I       Screening & Selection Performa 
Form II     Patient information sheet 
FormIII     Consent form 
Form IV    History Perform 
Form V      Drug compliance 
Form VI     Withdrawal 
Form VII   Adverse reaction 
Form VIII   Pharmaco vigilance 
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PREPARATION OF THE TRIAL DRUG: MOOKURATTAI ENNEI 
 
Authour Name :  Dr.Ponkurusironmani, (Balavagadam)  
Publisher Name :  Dr.K.S.Murugesamuthaliyar. page no 513.Year:1933. 
 
INGREDIENTS:                    
· Mookurattai (Boerhaavia diffusa)    - 1 padi(1 litre) 
· Saaranai (Trianthema decandra)   -  1 padi 
· Mudakatran (Cardiospermum halicacabum)  - 1 padi 
· Mutherukkan sevi ( Asarum europaeum)  - 1 padi 
· Orithal thamarai (Ionidium  suffrutiocosum)  - 1 padi                        
· Seppu nerunjil (Indigofera enneaphylla)   - 1padi                 
· Amanakku nei(Ricinus communis)     - 1 padi 
· Mayeliragu sambal (peacock feather)     - 1 palam(40gram)          
                               
 The required drugs will be purchased from a well reputed country shop and 
raw drugs are authenticated by the medicinal botanist of NIS. The medicine will be 
prepared in Gunapadam lab of National Institute of Siddha after proper purification. 
The prepared medicine will also be authenticated by the concerned Head of the Dept 
for its completeness. 
 
PURIFICATION: 
Mookurattai : Remove the veins of leaves  
Saranai : wash it in plaint water and remove the outer skin and cut it in to pieces 
later dry it  in shade  
Mutheruken sevi: Remove the veins of leaves and wash it  
Mudakkattran :  Remove the veins of leaves and wash it 
Oridhal Thamarai: Remove the veins of leaves and wash it 
 
PREPARATION METHOD  
              In a mud pot about 1.3 lit of each juice mentioned on the ingredients are taken 
and mixed with 1.3 lit of castor oil. Then the ashes of the peacock feathers are mixed to it 
and boiled till it reaches the required consistency. Then it is stored in a clear air tight 
conta 
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DOSAGE OF DRUGS : 1.6ml (od) 
DURATION    :  3 days  
DRUG STORAGE  :  Prepared medicine in  oil  form will be  stored  in  
clear air tight container. 
DISPENSING  :  1.6   ml of  Prepared medicine  will be given in oil  
form  in air  tight container. 
 
ASSESMENTS AND INVESTIGATIONS  
A. Clinical assessment  
B. Siddha method of assessment  
  
A. CLINICAL ASSESSMENT  
· History Taking 
· Physical Examination 
B. SIDDHA METHOD OF ASSESSMENT 
· Nilam 
· Kaalam 
· Uyirthathukkal 
· Udalthaathukkal 
· Envagaithervgal 
 
 
 
 
 
  
  
 
 
 
 
RESULTS 
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RESULTS AND OBSERVATIONS 
 
Preclinical studies: 
Physicochemical analysis of Mookurattai ennai 
 
Parameter Observation 
Color Greenish 
Smell Characteristic Odour 
Touch Oily 
Appearance Clear 
 
 
No Parameter Mean (n=3) SD 
1 Loss on Drying at 105 °C (%) 2.7 ± 0.75 
2 Total Ash (%) 0.45 ± 0.08 
     
 
S.No Specific Test MO 
1 pH 6 
2 Refractive index 1.36 
3 Iodoine value (mg I2/g) 109 
4 Saponification Value  (mg of KOH to saponify 1gm of fat) 204 
5 Specific Gravity 0.9721 
6 Viscosity 60.84 Centipoise (CP) 
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PHYTOCHEMICAL ANALYSIS 
      Test for Alkaloid- Mayer's reagent     Test for flavonoid 
           
 
 
 
 
 
 
 
 
 
 
         Test for Glycosides -Borntrager’s Test     Test for Triterepnoids 
    
 
 
 
 
 
 
 
 
  
 
Test for Steroids - Salkowski test Test for Carbohydrates - Benedict’s test 
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    Test – Phenol- Lead acetate test                  Test for tannins 
        
  
 
 
 
 
 
 
 
 
 
 
 
 
 
       Test for Saponins  Test for Proteins (Biuret Test) 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Test of Coumarins                Test for Anthocyanin 
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RESULT ANALYSIS 
 
PHYTOCOMPONENTS MO 
ALKALOIDS + 
FLAVONOIDS - 
GLYCOSIDES - 
STEROIDS + 
CARBOHYDRATES + 
TRITEREPNOIDS + 
COUMARINS + 
PHENOLS + 
TANNINS + 
SAPONINS + 
PROTEINS - 
ANTHOCYANIN - 
BETACYANIN - 
 
+   Indicates positive / Presence 
- Indicates Negative / Absence  
 
Quantitative estimation of phytoconstituents of MO: 
HPTLC CHROMATOGRAM OF MO 
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Peak Table of HPTLC finger printing of MO 
 
S.No Rf Height Area λ max 
1 0.92 18.0 1053.1 366 
2 0.31 22.6 1812.4 366 
3 0.24 2.6 1222.3 366 
4 0.16 12.4 1027.4 366 
5 0.71 24.6 1430.2 366 
 
Pharmacological Activity of Mookurattai ennai : 
Anti-Bacterial activity: 
Organisms used for Anti-Bacterial Activity 
 
S.No Organisms 
1.  Escherichia coli 
2.  Salmonella Typhi 
3.  Shigellasonnei 
4.  Vibrio Cholera 
 
Zone of Inhibition data of Anti-bacterial activity  
Sample Code E. Coli Salmonella Typhi Shigellasonnei Vibrio Cholera 
Concentraion 
500 
µg 
1000 
µg 
2000  
µg 
500 
µg 
1000 
µg 
2000  
µg 
500 
µg 
1000 
µg 
2000  
µg 
500 
µg 
1000 
µg 
2000  
µg 
MO - - 2 - - 5 - 2 4 - - - 
Ciprofloxacin 
(5µg) 
23 26 22 18 
 
 =  Not active 
 
Conclusion 
From the results of the present study it was concluded that the sample MO is 
effective against Shigellasonnei , Salmonella Typhi  and Moderately effective against E-
Coli and not effective against  Vibrio Cholera 
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Anti-Bacterial Evaluation of MO 
Anti- Microbial Effect of MO against E-Coli 
 
 
 
 
 
 
 
 
 
 
 
 
Anti- Microbial Effect of MO against Salmonella Typhi 
 
 
 
 
 
 
 
 
 
 
 
          
 
 
 
59 
 
 
Anti- Microbial Effect of MO against Shigellasonnei 
 
 
 
 
 
 
 
 
 
 
 
 
Anti- Microbial Effect of MO against Vibrio Cholera 
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GC-MS CHROMATOGRAM OF MO 
 
 
 
Peak Report of MO 
 
# RT [min] Area 
1 2.9 6.16 
2 11.1 3.51 
3 17.9 2.9 
4 33.1 6.8 
5 35.0 3.52 
6 36.6 64.7 
7 39.8 12.41 
 
 
Report Analysis 
GCMS analysis of the sample MO reveals the presence of most significant 
compound like Isothymol - a phenol derivative, oleic acid, Ascorbic acid derivatives and 
Ricinoleic acid derivatives.  
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PEAK 1 
 
 
PEAK 2 
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PEAK 3 
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PEAK 4 
 
 
PEAK 5 
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PEAK 6 
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PEAK 7 
 
 
 
Biochemical analysis 
Results of Acid radicals studies 
 
S.NO Parameter Observation Result 
1 Test for Sulphate No Cloudy appearance Present Negative 
2 Test for Chloride Cloudy appearance    present Positive 
3 Test For Phosphate No Cloudy  yellow     appearance 
present Negative 
4 Test For Carbonate  - Negative 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluoride 
&oxalate 
- Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Interpretation 
 The acidic radicals test shows the presence of chloride. 
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Results of basic radicals studies: 
 
S.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium Brown colour present Positive 
4 Test For Iron - Negative 
5 Test For Zinc - Negative 
6 Test for Calcium - Negative 
7 Test For Magnesium - Negative 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
Interpretation 
 The basic radical test shows the presence of Aluminium and absence of heavy 
metals such as lead, Iron, arsenic and mercury. 
 
Miscellaneous: 
 
S.NO Parameter Observation Result 
1 Test for Starch - Negative 
2 Test for Reducing sugars - Negative 
3 Test For Alkaloids - Positive 
4 Test For Tannic acid Blue-black precipitate obtained Positive 
5 Test for unsaturated 
compounds 
- Negative 
6 Test for Amino acid - Negative 
 
Interpretation 
The Miscellaneous test shows the presence of  Alkaloids and Tannic acid. 
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CLINICAL STUDIES 
 
 40 Patients with confirmed diagnosis of with satisfying the inclusion criteria were 
enrolled after obtaining written informed consent and were to receive Mookurattai ennai 
with dosage of 1.6 ml od for 3 days 
 
Results were observed with respect to the following criteria: 
1. Age 
2. Sex          
3. Parent’s Socio Economic Status    
4. Diet 
5. Nilam 
6. Paruvakaalam 
7. Uyirthathukkal 
8. Ezhuudalkattugal 
9. Envagaithervugal 
10. Neikuri 
11. Clinical features 
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Table 1: Distributions of patients with Kanakazhichal  according to Age 
 
S.NO AGE NO.OF.CASES PERCENTAGE% 
1. >5- <6 Years 10 25 
2. >6- <7Years 10 25 
3. >7- <8 years 3 7.5 
4. >8 -<9years 5 12.5 
5. >9- <10 years 5 12.5 
6. >10- <11years 5 12.5 
7. >11-<12 years 2 5 
 
 
 
Inference: 
 Out of 40 patients, 25 % of cases were 5-6years, 25 % were 6-7 years, 7.5% were 
7-8 years 12.5% were 8-9 years, 12.5% were 9-10 years, 12.5% were 10-11 years, 5% of 
cases were 11-12 years. (Table -1) 
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Table 2: Distribution of patients with Kanakazhichal according to Gender: 
 
 
S. No Gender No. of cases Percentage   
1 Male child 22 55% 
2 Female child 18 45% 
  
 
 
 
        
Inference: 
Out of 40 patients 55% were male children and 45% were female children. 
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Table 3: Distribution of patients with kanakazhichal according to religion: 
 
S.No Religion No of cases Percentage  
1 Hindu 37 92.50% 
2 Muslim 3 7.50% 
3 Christian 0 0 
                    
 
 
 
 
Inference: 
Out of 40 Patients 7.5% cases of were muslim, and 92.5% cases of were hindu. 
 
 
 
 
 
 
 
Hindu
92.50%
Muslim
7.50%
Religion Distribution
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Table 4: Distribution of patents with Kazhichal according to socio- economic status: 
 
S.No Socio Economic status No.of cases Percentage 
1 Upper class 9 22.5 
2 Upper Middle class 24 60 
3 Upper lower class 7 17.5 
 
 
 
 
Inference: 
About 17.5 % patients were under lower income group, 60% patients were under 
middle income group and 22.5% patients were under high income group.  The highest 
incidence occurred in middle  income group.(Table 4). 
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Table 5: Distribution of patients with Kanakazhichal according to diet reference: 
 
S.No Food habits No.of cases Percentage 
1 Vegetarian 3 7.5 
2 Non- Vegetarian 37 92.5 
 
 
 
  
Inference: 
 According to diet, Vegeterian 7.5%, Mixed 92.5% were noted. (Table: 5) 
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Table 6: Distribution of Patients with Kanakazhichal according to Nilam: 
 
Nilam No.of cases Percentage 
Kurinji 0 0 
Mullai 0 0 
Marutham 2 5 
Neithal 38 95 
Paalai 0 0 
 
 
 
 
Inference: 
Among 40 patients, 95 % were from Neithal land, 5 % from Marutham land 
(Table 6) 
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Table 7: Distribution of patients with Kanakazhichal according to Paruvakalangal 
 
S.No Paruvakalam No.of 
cases 
Percentage 
1 Karkaalam (Avani-Puratasi) 5 12.5% 
2 Koothirkaalam (Iyppasi- Karthika) 0 0% 
3 Munpanikalam (Markazhi- Thai) 5 12.5% 
4 Pinpanikalam (Masi- Panguni) 12 30% 
5 Elavenil (Sithirai- Vaikasi) 17 42.5% 
6 Muthuvenil (Aani –Aadi) 1 2.5% 
 
 
 
Inference: 
According to elavenil kaalam, high incidence of cases42.5% were reported in 
Pinpanikalam,27.5% cases were reported in pinpani kalam, 2.5% cases were reported in 
elavenil kaalam and 2.5% were from Karkalam,elaveil kalam and kuthirkalam .(Table:7) 
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Table 8: Distribution of patients with Kanakazhichal according to  
derangement of Vatham: 
 
S.No Vatham No.of cases Percentage 
1 Pieanan 0 0% 
2 Ahanam 40 100% 
3 Viyanam 40 100% 
4 Uthanan 0 0% 
5 Samanan 40 100% 
6 Nagan 0 0% 
7 Koortham 0 0% 
8 Kirukaram 0 0% 
9 Devathathan 10 25% 
10 Dhanajeyam 0 0% 
 
 
 
 
 
Inference: 
According to vatham, derangement of Pranan was 0%, Abanan was 
100%,Viyanan was 100% ,Udhanan was 0%, samaanam was affected 100 % and 
Devathathan was deranged in 25%%(Table 8a). 
Abanan
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31%
Samanan
31%
Devathathan
7%
DISTRIBUTION OF VATHAM
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Table  8(B) :  Distribution of patients with kanakazhichal according to derangement 
of Pitham: 
 
S.No Types of Pitham No of cases Percentage 
1 Anarpitham 40 100% 
2 Ranjagam 0 0% 
3 Saathagam 0 0% 
4 Prasagam 0 0% 
5 Alosagam 0 0% 
 
Inference: 
According to Pitham, derangement of Analapitham was 100%and Ranjagam was 
0% (Table 7b). 
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Table 8 C: Distribution of patients with kanakazhichal according to derangement of 
Kabam: 
 
S.No Types of Iyyam No of cases Percentage 
1 Avalambagam 40 100% 
2 Kilethagam 40 100% 
3 Pothagam 0 0% 
4 Tharpagam 0 0% 
5 Santhigam 0 0% 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference :  
According to Kabam, derangement of Kelathagam was deranged in 100% and  
Kilethagam was 100% (Table7c). 
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Table 9: Distribution of patients with kanakazhichal according to derangement of 
Ezhuudarkattugal: 
 
S.No Udarkattugal No of cases Percentage 
1 Saaram 40 100% 
2 Senneer 0 0% 
3 Oon 0 0% 
4 Kozhuppu 0 0% 
5 Enbu 0 0% 
6 Moolai 0 0% 
7 Sukkilam/Surohitham 0 0% 
 
 
Inference: 
Saram was affected in 100% of cases.   (Table:9). 
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Table 10 : Distribution of patients with kanakazhaichal according to derangement of 
Enn vagai thervugal: 
 
S.No Envagai thervugal Percentage 
1 Naa 0% 
2 Niram 0% 
3 Mozhi 0% 
4 Vizhi 0% 
5 Malam 100% 
6 Moothiram 0% 
7 Naadi 100% 
8 Sparisam 0% 
 
 
Inference: 
Out of 40 cases Malam was affected in100% of cases, Sparism was affected in  
15% of cases ,Naa and Vizhi  was affected in 10%of the cases.(Table:10) 
 
Inference (Naadi): 
In Naadi, Vathapitham was observed in 50 % of cases, Pithavatham was observed 
in 50 % of cases. 
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Table 11: Neikuri Analysis: 
 
S.No Character of urine Neikuri Reference No of cases Percentage 
1 Spreads like Snake Vatha neer 32 80% 
2 Spreads like ring Pitha neer 8 20% 
3 Static as pearl Kaba neer 0 0% 
 
 
 
 
Inference 
According to Neikuri, Vatha neer was observed in 80  % of cases, pitha neer was 
observed in 20 % of cases, of cases.(Table: 11) 
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Table 12: Kanakazhichal using Vesikari scoring system: 
  
Variables Before After Percentage 
Frequency of stools 72 41 42 
Duration 47 40 15 
Stool consistency 98 46 53 
Abdoman pain 95 49 48 
Fever 48 43 10 
 
 
 
Inference 
Frequencey of Stools  reduced in 42 % of cases, duration reduced in 15% ,  Stool 
cibsustebct 53%, Abdominal pain reduced in  48%, Fever reduced in 10% of cases. 
(Table: 12) 
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Table:13  Kanakazhichal scoring system: 
The scoring table for   Kanakazhichal patients are categorized as mentioned below 
 
Treatment 
Severity Category 
Mild  Moderate Severe Total 
Before 
Treatment 0 34 6 40 
After 
Treatment 26 14 0 40 
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STASTICAL ANALYSIS : 
 All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. STATA software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross- tabulations were 
performed. Bar diagram, Pie charts were used to describe the value of different variables 
for pictorial representation. The quantity variables were expressed as Mean and standard 
deviation and qualitative data as percentage. A probability value of less than 0.05 was 
considered to indicate as statistical significance. Paired‘t’ test was performed for 
determining the significance between before and after treatment. 
 
Paired Samples Statistic 
S.No   Mean Std. Deviation 
Std. Error 
Mean 
1 Before 9.0000 1.46760 .23205 
2 After 5.5000 .75107 .11875 
 
 
Paired Sample Test: 
Table : Clinical symptom  score  of Mookurattai ennai. 
     
S.No   
Paired Difference 
t 
sig.(2 
tailed) 
P-Value Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval 
Upper Lower 
1 Before – After 3.5000 1.5021 0.2375 3.0196 3.9804 14.736 0.000 
 
Result: 
I. The mean and SD of clinical symptom score of Mookurattai ennai,before   and 
after treatment were 9.0000+1.46760 and 5.5000+.75107 respectively which is 
statistically significant. (t-value 14.736,p<0.0001). 
II. P<0.05- reject null hypothesis. 
III. There is significance difference between before and after treatment. 
Thereduction of clinical symptoms is 39%. 
  
 
 
 
 
 
DISCUSSION 
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DISCUSSION 
 Kana Kazhichal is a common pediatric problem.This disease has been clearly 
described in several siddha texts.Kanakazhichal mostly resembles in bacillary  dysentery 
in modern aspects.This is characterised by passing loose stools with blood or mucous, 
fever, abdominal pain, tenesmus. 
  
 In this study several cases were treated at the out-patient P.G Kuzhandhai 
Maruthuvam department at National Institute of Siddha , Chennai-47. According to 
clinical features mentioned in siddha texts.Siddha methods of diagnosis were carried out 
and recorded in proforma.The diagnosis were confirmed and treated with trial drug 
‘Mookurattai ennai” and clearly observed.The observations are discussed here.             
  
 The drugs which are mentioned in Siddha literature for the management of 
Kanakazhichal  were selected and the study is conducted after the proposal was screened 
by the Screening committee of National Institute of Siddha and the trial was also 
approved by the Institutional Ethical Committee (IEC). The trial was registered in 
Clinical trial registry of India. 
             
 The trial drugs were prepared by the Author in the Gunapadam practical 
laboratory of National Institute of Siddha, after getting proper authentication of raw drugs 
from the Medicinal botany department at NIS, Chennai 47. The trial drug was prepared 
by the standard operating procedure as mentioned in the protocol. 
 
The chemical analysis and physiochemical analysis of drugs were performed in 
biochemistry lab of NIS, and sathyabaama univercity, Chennai. The safety of the trial 
drug usage through biochemical analysis was also ensured during the study. It revealed 
the presence of effective minerals. 
 
The patients were recruited for the trial based on inclusion and exclusion criteria 
and after getting the consent from the patient. 40 patients were included in this study.  
The 40 patients were treated in OPD  of Ayothidoss Pandithar Hospital of National 
Institute of Siddha. Separate proforma was maintained for every patient. Progress chart 
was also maintained to monitor the clinical signs and symptoms of the disease.  
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The treatment was aimed at normalizing the deranged thodams and providing 
relief from symptoms. Before treatment the patients were advised to adapt lifestyle 
modifications such as oil bath weekly once and to follow good dietary regimen. 
 
The patients were treated with trial drug MOOKURATTAI ENNAI  for 3 days. 
Patients were instructed to take the medicines regularly and advised to follow pathiyam 
and to avoid intake of contaminated foods if any. Patients were asked to visit the hospital 
on 4th day. 
 
 After completion of the study, the patients were advised to visit the Out-Patient 
ward of Department of Kuzhanthai Maruthuvam for 1 month for follow-up. The results 
observed during the study period were discussed by the author below.   
 
This study evaluates the effect of MOOKURATTAI ENNAI” in relieving the 
symptoms of KANAKAZHICHAL. 
 
Incidence with refrence to age: 
 
Out of 40 patients, 25 % of cases were 5-6years, 25 % were 6-7 years,7.5% were 
7-8 years12.5% were8-9 years, 12.5% were 9-10 years,12.5%were 10-11 years,5%of 
cases were 11-12 years.  
 
Incidence with refrence to sex: 
Out of 40 patients55% were male children and 45% were female children.   
 
Incidence with refrence to religion: 
Out of 40% 7.5%cases of muslim,and 92.5%cases of hindu. 
 
Incidence with refrence to socioeconomic  
 About 17.5 % patients were under lower income group, 60% patients were under 
middle income group and 22.5% patients were under high income group.  The highest 
incidence occurred in middle  income group. 
 
Incidence with refrence to food habits: 
According to diet, Vegeterian 7.5%, Mixed 92.5% were noted.  
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Incidence with refrence to nilam: 
Among 40 patients, 95 % were from Neithal land,5 % from Marutham land, 0 % 
from Mullai land, and 0% from Kurinji land. 
  
Incidence with refrence to paruvakalangal: 
According to elavenil kaalam, high incidence of cases42.5% were reported in 
Pinpanikalam,27.5% cases were reported in pinpani kalam, 2.5% cases were reported in 
elavenil kaalam and 2.5% were from Karkalam,elaveil kalam and kuthirkalam . 
 
Incidence with reference to mukkutram: 
 With reference to siddha texts mukkutram were analysed in the following pattern. 
 
Vatham: 
 According to vatham, derangement of Pranan was 0%, Abanan was 
100%,Viyanan was 100% ,Udhanan was 0%, samaanam was affected 100 % and 
Devathathan was deranged in 25%%. 
 
pitham: 
 According to Pitham, derangement of Analapitham was 100%and Ranjagam was 
0% . 
  
kabam: 
According to Kabam, derangement of Kelathagam was deranged in 100% and  
Kilethagam was 100% . 
 
Incidence with refrence to Ezhuudarkattugal: 
Saram was affected in 100% of cases. 
  
Incidence with refrence to Envagaithervugal:  
          Out of 40 cases Malam was affected in100% of cases, Sparism was affected in   
15% of cases ,Naa and Vizhi  was affected in 10%of the cases.(Table:10) 
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Inference (Naadi): 
In Naadi, Vathapitham was observed in 50 % of cases, Pithavatham was observed 
in 50 % of cases. 
 
Inference (Neerkuri): 
According to Neikuri, Vatha neer was observed in 80  % of cases, pitha neer was 
observed in 20 % of cases, of cases. 
 
Treatment: 
 If the cases suffering from KanaKazhichal are not timely diagnosed and treated, it 
will leads to certain complications. They are ulceration of colon, weakened pulse,In 
modern system also the important complications explained are severe thirst, electrolyte 
loss, oliguria,and rectal prolapse etc. 
 In order to prevent the complications in the patients with KanaKazhichal and treat 
the patients with the trial medicine “Mookurattai ennai” was given one  time a day for 3 
days. 
All the patients were strictly advised to follow pathiyam.They were also advised to follow 
personal hygiene and other preventive measures.Satisfactory improvement  was reported 
within 3 days of commencement of the treatment. 
 
Clinical presentation: 
 In the clinical trial of the 40 patients Frequency of stools reduced in 42% of 
cases,duration reduced in 15%,stool consistency 53%,Abdominal pain 
48%,Fever10%.The clinical improvement were accurately noted and further followup 
was made in outpatient department. 
 
Chemical analysis of trial medicine: 
 The biochemical analysis of the trial medicine showed the presence of Tannic 
acid,  Aluminium,  chioride. 
 
Physiochemical analysis of the trial medicine:  
 The physio chemical analysis of the trail drug showed the presence of Loss of 
drying at 1050C(%)  2.7+0.75,total ash,Ph- 6,Refractive  index-1.36,Iodine value (12/g)-
109.Saponification value-204,Specific gravity-0.9721. 
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Antibacterial Study on Mookurattai ennai: 
 Four organism have been studied for Antibacterial property of  Mookurattai ennai. 
Effective against shigellasonnei, Salmonella typhi and moderately effective against E-coli 
and not effective against Vibrio Cholera.  
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SUMMARY 
 
Patients attending the OPD of NIS having the compliants of Kanakazhichal 
diagnosed clinically are the study subjects of this Clinical study. Classical symptoms of 
Kanakazhichal emphasis with the symptoms of Bacillary dysentery  like Passing loose 
stools with blood or mucus, fever, abdominal pain, tenesmus.  
 
The Clinical study has been approved by IEC of NIS, approval 
No:NIS/IEC/9/2014-15/19-26-08-2014.The trial registred in Clinical trial Registry of 
India with Reg .No.CTRI/2017/02/007952. The Authentication of ingredients of the trial 
drug was obtained from Medicinal Botanist, National Institute of Siddha, Chennai. 
Purification of raw drugs and preparation of trial drug was done at Gunapadam 
Laboratory, Department of Gunapadam, NIS Chennai.  
 
Physicochemical analysis of trial drug was done Sathyabama University, Chennai 
and Phyto chemical analysis was done in Biochemistry laboratory of National Institute of 
Siddha, Chennai.  
 
Clinical diagnosis of Kana Kazhichal was done on the basis of clinical features  
described in Kuzhandhai Maruthuvam, Siddha maruthuvam, Noi naadal and Noi mudhal 
naadal thiratu etc. 
 
The etiology and clinical features of Kana Kazhichal were correlated with the 
etiology and clinical features of Bacillary dysentery. 
 
Dehydrated children, children having lactose intolerance, ulcerative colitis, 
chronic diarrhea and child in need of emergency treatment were excluded from this study. 
Siddha system of clinical methods like Envagai thervugal, Neerkuri, Neikuri were 
carried out in all the patients and recorded. 
 
The trail medicine Mookurattai ennai was given internally once in  a day for 
3days.The dosage of the trail drug is Uchikarandialavu (1.6ml). 
 
The observation made during the clinical study showed that the trial drug 
Mookurattai ennai was clinically effective (39%) for Kanakazhichal. 
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The Phytochemical analysis of the trial medicine showed the presence of tannic 
acid, aluminium and chloride.  
 
The physio chemical analysis of the trail drug showed that Loss of drying at 
1050C(%)  2.7+0.75, total ash value 0.45+0.08, Ph-6, Refractive  index-1.36, Iodine value 
(12/g)-109. Saponification value-204, Specific gravity-0.9721 
 
Four organism have been studied for Antibacterial property of  Mookurattai ennai. 
Among the 4 organism effective inhibitory actions found against shigella sonnei, 
Salmonella typhi and moderately effective against E-coil and  not effective in Vibrio 
Cholera.  
 
The parents and children were adviced to follow the preventive measures and to 
lead a hygienic life. 
 
The  clinical efficacy  of  the  drug  was  analyzed  statistically  on  all  the  symptoms 
mentioned  in  the  assessment  criteria.  The observation made during the clinical study 
showed that the trail drug Mookurattai ennai was clinically effective( 39%) 
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CONCLUSION 
 All the fourty patients (Childrens)  in Dept. of  Kuzhandhai Maruthuvam, National 
Institute of Siddha, Chennai-47 with Kanakazhichal were treated with Mookurattai ennai  
1.6ml (Uchikarandialavu)  once in a day  for 3 days.  
 
 No adverse effects were found during the treatment period. The trial drug 
Mookurattai ennai is purely herbal and the raw drugs are easily available and it is 
harmless to childrens. 
 
 The method of preparation is easy and the cost is comparatively economical. 
 The drugs has got Anti bacterial action against  Shigella sonnei , Salmonella Typhi  
and Moderately effective against E.Coli.  
 
 The Clinical  study results were found to be good in 39%.  Because of the 
encouraging results, the study may be undertaken with same medicine in a large number 
of cases further. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL 
(BACILLARY DYSENTERY)  IN CHILDREN. 
FORM I - SCREENING 
1. Sl. No:        2. OP / IP No:                      3. Name:                                                  
4. Age:          5. Sex:    6. Date:       
7. Informant:                   8. Reliability:       
   
IINCLUSION CRETERIA:                                           YES                NO 
       Age: between 5-12 years 
       Frequent  passing  of stools with mucus 
       at least 3 or 4 times per day   
       Fever        
       Abdominal pain                 
EXCLUSION CRITERIA: 
       Child below 5 years 
       High grade fever                            
       Severe dehydration  
       Extra intestinal complication  
       Chronic diarrhoea 
  
ADMITTED TO STUDY 
 
YES  NO  
If Yes, OPD  IPD  
 
 
 
Date:        
Station: 
Signature of the Guide                                                                 
 
Signature of the HOD   Signature of the  Investigator 
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                                       NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
                              DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL  
                                                    (BACILLARY DYSENTERY)  IN CHILDREN 
 
     FORM II – PATIENT INFORMATION SHEET 
I, Dr.S.Arunasalam. studying as PG Scholar in department of Kuzhanthai 
Maruthuvam at National Institute of Siddha, doing a study on Clinical Evaluation of 
Mookurattai  Ennai for kanakazhichal (bacillary dysentery) in children. I will maintain 
confidentiality of your comments and data obtained. There will be no risk of disclosing 
your identity and no physical, psychological or professional risk is involved by taking 
part in this study. No compensation will be paid to you for taking part in this study. 
           You can choose not to take part. However, taking part in the study may be of 
benefit to the scientific community, as it may help us to understand the problem of the 
disease and find the potential solution. 
             If you agree your child to be a participant in this study, he/she will be included in 
the study primarily by signing the consent form and then you will be given the internal 
medicine Mookurattai Ennai 1.6 ml once a day at morning for 3 days. 
The information I am collecting in this study will remain between you and the 
investigator (myself).  
If you wish to find out more about this study before taking part, you can ask me 
directly or through my mobile number 7358306605. You can also contact the Member-
secretary of Ethics committee, National Institute Siddha, Tel no: 0-44-22380789.  
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Njrpa rpj;j kUe;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47 
gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw 
fzfopr;ry; Neha;f;F %f;Ful;il vz;nzapd; ghpfhpg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;T 
gbtk; 2 jfty; gbtk;  
 Njrpa rpj;j kUj;Jt epWtdj;jpy; Foe;ij kUj;Jtj;Jiwapy; gl;;l Nkw;gbg;G 
gapd;W tUk; kU.nrh.mUzhryk; Mfpa ehd; fzfopr;ry; Neha;f;F %f;Ful;il 
vz;nzapd; ghpfhpg;Gj; jpwidf;; fz;lwpAk; kUj;Jt Muha;r;rpapy; <Lgl;Ls;Nsd;. ,J 
rk;ge;jkhf ngwg;gLk; Foe;ijapd; midj;J tptuq;fSk; ,ufrpakhf itf;fg;gLk; vd 
cWjp mspf;fpNwd;. ,J Nghd;w tptuq;fis njuptpg;gjhy; jq;fSf;Nfh jq;fsJ 
Foe;ijf;Nfh jq;fspd; Ntiy jsj;jpNyh ve;j xU ghjpg;Gk; Vw;glhJ. ,jpy; gazg;gb 
Kjypa ve;j cjtpj;njhifAk; toq;fg;gkhl;lhJ. 
     ,e;j Muha;r;rpf;F Nehapduhf Nru;e;j gpwF cq;fSf;F tpUg;gk; ,y;iynadpy; 
vg;NghJ Ntz;LkhdhYk; jq;fsJ Foe;ijia tpyf;fpf; nfhs;syhk;. ,Ue;jhYk; ,e;j 
kUj;Jt Ma;tpy; Nrh;tjd; %ykhf jq;fsJ Foe;ijapd; Neha; FiwtJ kl;Lky;yhky; 
kUj;Jtj;Jiw rhHe;j ty;YeHfSf;F ,e;j Neha;f;fhd jPh;Tfis fz;lwptjw;F kpfTk; 
cjtpahf ,Uf;Fk;. 
,e;j Muha;r;rpf;F jq;fsJ tpUg;gj;jpd; Ngupy; jq;fsJ Foe;ijia cl;gLj;Jk; 
gl;rj;jpy; Kjypy; xg;Gjy; gbtj;jpy; ifnaOj;jpl;l gpd;G jhq;fs; jq;fs; Foe;ijf;F 
cs;kUe;jhf %f;Ful;il vz;nza; 1.6 kp.yp 3 ehl;fs; xUNtis fhiyapy; ju 
Ntz;Lk;. 
,e;j kUj;Jt Ma;tpd; njhlHghf cq;fsplkpUe;J Nrfupf;fg;gLk; midj;J 
tptuq;fSk; cq;fSf;Fk; Muha;r;rpahsuhd vdf;Fk; kl;LNk mwpe;jpUf;ff; $bajhf 
,Uf;Fk;. 
 ,e;j Muha;r;rp rk;ke;jkhf kw;w tpguq;fisAk; Nehapd; jd;ik gw;wpAk; 
mwptjw;F Muha;r;rpahsuhd kU.nrh.mUzhryk; ifNgrp vz; 7358306605 njhlu;G 
nfhs;syhk;. NkYk; ,e;j Muha;r;rp njhlu;ghf epWtd ePjp newp FO, Njrpa rpj;j 
kUe;Jt epWtdk;, njhiyNgrp vz; 0-44-22380789 njhlu;G nfhs;syhk;. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
                              DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL  
(BACILLARY DYSENTERY)  IN CHILDREN. 
FORM III – (A) CONSENT FORM  
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Date:        Signature: 
Station:       Name: 
CONSENT BY PARENT  
 I have been informed to my satisfaction, by the attending physician, the purpose 
of the clinical trial, and the nature of drug treatment and follow-up to monitor and 
safeguard my son/daughter’s body functions.I am aware of my right to opt my 
son/daughter out of the trail at any time during the course of this study without having to 
give the reasons for doing so.  
            I exercising my free power of choice, hereby give my consent to include my 
son/daughter as a subject in the CLINICAL EVALUATION OF  MOOKURATTAI  
ENNAI FOR KANAKAZHICHAL (BACILLARY DYSENTERY)  IN CHILDREN. 
Date:       Signature of the parent: 
Station:      Name: 
       Signature of witness: 
       Name: 
Relationship of the witness:   
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Njrpa rpj;j kUe;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47 
gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw 
fzf;fopr;ry; Neha;f;F %f;Ful;il vz;nzapd; ghpfhpg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;T 
xg;Gjy; gbtk; - III (A) 
Ma;thsuhy; rhd;wspf;fg;gl;lJ 
ehd; ,e;j kUj;Jt Ma;it Fwpj;j midj;J tpguq;fisAk; Nehahspapd; ngw;NwhUf;F 
GhpAk; tifapy; vLj;Jiuj;Njd; vd cWjp mspf;fpNwd;. 
Njjp:        ifhg;gk;: 
,lk;:         ngah;:  
Nehahspapd; ngw;Nwhh; xg;Gjy;  
vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk;> kUe;jpd; jd;ik kw;Wk; kUj;Jt 
topKiwg; gw;wpAk;> ,e;j kUj;Jtj;ij njhlh;e;J vdJ Foe;ijapd; cly; ,af;fj;ijf; 
fz;fhzpf;fTk;> mjidg; ghJfhf;f gad;gLk; kUj;Jt Ma;Tfs; gw;wpAk; jpUg;jp 
mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; vg;nghOJ 
Ntz;LkhdYk; vd; Foe;ijia tpLtpj;Jf; nfhs;Sk; chpikia njhpe;jpUf;fpNwd;.   
ehd; vd;Dila Rje;jpukhf Njh;T nra;Ak; chpikiaf; nfhz;L fzf;fopr;ry;  
Neha;f;fhd %f;Ful;il vz;nzapd; ghpfhpg;Gj; jpwid fz;lwpTk; kUj;Jt Ma;tpw;F 
vdJ Foe;ijia cl;gLj;j xg;Gjy; mspf;fpNwd;. 
Njjp:         ngw;nwhh; ifnahg;gk;: 
,lk;:        ngaH: 
         rhl;rpf;fhuu; ifnahg;gk;: 
         ngau;:  
        rhl;rpf;fhuu; cwT Kiw: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL 
(BACILLARY DYSENTERY)  IN CHILDREN 
FORM - III(B) ASSENT FORM  (By Patient) 
  I, _________________________ understand that my 
parents______________ (mom and dad)/ guardian have/ has given permission (said it's 
okay) for me to take part in this study entitled “CLINICAL EVALUATION OF 
MOOKURATTAI ENNAI FOR KANAKAZHICHAL (BACILLARY DYSENTERY) IN 
CHILDREN” done by Dr.S.Arunasalam. 
  I am taking part because I want to take part. I have been told that I can stop 
at any time. I want to do so and nothing will happen to me if I want to stop. 
Date:       Signature of the patient:  
  
Station:      Name:  
       Signature of the parent: 
       Name: 
       Signature of the witness: 
       Name: 
Relationship of the witness:  
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Njrpa rpj;j kUe;Jt epWtdk; 
mNahj;jpjhr gz;bjH kUj;Jtkid> nrd;id-47 
gl;lNkw;gbg;G Foe;ij kUj;Jtj;Jiw 
fzf;fopr;ry;  Neha;f;F %f;Ful;il vz;nzapd; ghpfhpg;Gj; jpwidf; fz;lwpAk; 
kUj;Jt Ma;T 
xg;Gjy; gbtk-; III (B) Foe;ijf;fhdJ 
 ______________________ Mfpa ehd; Njrpa rpj;j kUj;Jt epWtdj;jpy; gl;lNkw;gbg;G 
Foe;ij kUj;Jtj;Jiwapy; gapYk; kU.nrh.mUzhryk; mtu;fshy; elj;jg;gLk; 
fzf;fopr;ry;   Neha;f;F %f;Ful;il vz;nzapd; ghpfhpg;Gj; jpwidf;; fz;lwpAk; kUj;Jt 
Ma;tpy; gq;Nfw;gjw;F vdJ ngw;NwhH/fhg;ghsu; jpU/jpUkjp.________________________ rk;kjk; 
njuptpj;jpUg;gij ed;F mwpNtd;.  
 vdf;F ,e;j Muha;r;rp gw;wp; GhpAk; tifapy; vLj;Jiuf;fg;gl;Ls;sJ. 
,t;thuha;r;rpapy; ,Ue;J vg;NghJ Ntz;LkhdhYk; tpyf vdf;F chpik ,Uf;fpd;wJ 
vd;gij gw;wpAk; ed;F njupe;J nfhz;L ,e;j Muha;r;rpapy; gq;Nfw;f rk;kjpf;fpNwd;.  
Njjp:       Foe;ijapd; ifnahg;gk;: 
,lk;:        ngah;: 
       ngw;nwhh; ifnahg;gk;: 
       ngaH: 
       rhl;rpf;fhuu; ifnahg;gk;: 
        ngau;:  
       rhl;rpf;fhuu; cwT Kiw: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
     DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL  
(BACILLARY DYSENTERY)  IN CHILDREN 
FORM IV-CASE REPORT FORM 
HISTORY TAKING 
OP/IP No. Visit Date : ( __/__/____ ) 
Name :  
Age    :  
Gender :  Male child 
                 Female child          
Date Of Birth : ( __/__/____ ) 
Father/ Mother /Guardian Name :  
Father’s Occupation :  
Father’s Monthly  Income :  
Religion :  
Socioeconomic Status :  
Informant : 
 
 
Postal Address 
 
 
 
 
Contact No : 
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Complaints and Duration: 
Present illness:  
 
 
 
History of Past Illness  
 
History /Symptoms/Signs  Yes    No  If, Yes Details  
Bronchial Asthma  
Dust Allergy 
Hospitalization 
Any other illness  
 
Family History 
Any Hereditary/ Familial Disease                      Yes                      No 
If Yes, Details ______________________________________________________ 
 
Immunisation History  
Proper Immunization given  Yes                     No           _____________________ 
Food habits: 
1. Veg  2. Non-Veg   
 
Personal habits:                       Yes                   No 
1. Picca  
2. Nail biting 
3. Bowel movements 
 
Nilam: 
General Examination                              YES                   NO 
1. Pallor       
2. Jaundice    
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3. Cyanosis    
4. Clubbing    
5. Pedal oedema    
6. Lymphadenopathy   
 
Vital signs: 
1. Pulse rate / minute 
2. Heart rate / minute 
3. Respiratory Rate / minute 
4. Temperature 
 
Anthropometry: 
          Height- 
          Weight- 
 
Systemic Examination : 
Gastro Intestinal System: 
 
INSPECTION:  
Shape of the Abdomen: Normal/Fullness/Distended/Scaphoid  
Abdominal movements : Inspiratory/Expiratory 
Scars                              :  Present/Absent   
Umblicus                       : Normal/Inverted/Everted 
Visible veins                 :  Present/Absent 
Peristaltic waves           :  Present/Absent 
Pulsations                     : Yes/No 
Groin/Scrotum             :  Normal/Affected 
 
PALPATION: 
Tenderness                   :  Present/Absent 
Palpable mass               :  Present/Absent 
Enlargement                 :  Present/Absent 
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PERCUSSION: 
Shifting dullness           :  Present/Absent 
Fluid Thrill                    :  Present/Absent 
 
AUSCULTATION: 
Bowel Sound                 :  Absent/Normal/Increased/Decreased 
 
OTHER SYSTEM:                         Normal                     Affected 
Cardio vascular system  :                                                  __________________ 
Respiratory system        :                                                 _____________________ 
Musculoskeletal system :                                                  ____________________ 
Central nervous system :                                                   ____________________ 
 Endocrine system           :                                                  __   ______________________         
  
CLINICAL EXAMINATION; 
S.NO CLINICAL SYMPTOMS 1st DAY 
1  Frequency of  loose stools  
2 Stool consistency  
3 Abdominal pain  
4 Fever  
 
SIDDHA BASED EXAMNATION: 
Kaalam 
     Kaarkalam                   Koothirkaalam              Munpanikaalam  
     Pinpanikaalam                  Illavenirkaalam             Muthuvenirkaalam 
Yaakai 
       Vatham         Vatha Pitham         Vatha Kabam 
       Pitham           Pitha vatham          Pitha Kabam 
       Kabam         Kaba Vatham         Kaba Pitham 
Gunam  
             Sathuvam   Rasatham             Thamasam 
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Pori / Pulangal 
Normal Affected Normal Affected Remarks 
Mei / unarvu                                                                                                    ________ 
Vaai / suvai                                                                                                      ________ 
Kan / paarvai                                                                                                   ________      
Mooku / naatram                                                                                              ________       
Sevi / olli                                                                                                          ________    
 
Kanmendhirium / Kanmavidayam 
Normal Affected Normal Affected Remarks 
Kai / dhanam                                                                                                       ________ 
Kaal / ghamanam                                                                                                ________ 
Vaai / vaaku                                                                                                        ________ 
 Eruvaai / visarkam                                                                                             ________ 
Karuvaai / Aanantham                                                                                        ________ 
 
Uyir Thathukkal 
Vatham 
   Normal         Affected  Remarks 
Pranan                                                                   _________________ 
Abanan                                                                         _________________ 
Viyanan                                                                   _________________ 
Uthanan                                                                       _________________ 
Samanan                                                                      _________________ 
Nagan                                                                   _________________ 
Koorman                                                                      _________________ 
Kirukaran                                                                     _________________ 
Devathathan                                                                 _________________   
Dhanajeyan                                                                   _________________     
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Pitham   
   Normal Affected  Remarks 
Analagam                                                                   _________________ 
Ranjagam                                                                   _________________   
Saathagam                                                                    _________________  
Alosagam                                                                    _________________ 
Prasagam                                                                       _________________ 
 
Kabam  
   Normal Affected  Remarks 
Avalambagam                                                               _________________   
Kilethagam                                                          _________________ 
Pothagam                                                                     _________________ 
Tharpagam                                                                     _________________  
Santhigam                                                                     _________________ 
 
Udalthathukkal 
    Normal Affected  Remarks 
Saaram                                                                             _________________ 
Senneer                                                                            _________________ 
Oon                                                                                  _________________ 
Kozhuppu                                                                        _________________ 
Enbu                                                                                 _________________ 
Moolai                                                                              _________________ 
Sukilam / Suronitham                                                       _________________  
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Envagai Thervugal  
                            Normal  Affected  Remarks 
Naa                                                                     _________________ 
Niram                                                                  _________________ 
           Thanmai                                                              _________________ 
           Suvai                                                                   _________________ 
            Niram                                                                      _________________   
 Mozhi                                                                  _________________  
 
Vizhi  
 Niram                                                                   _________________ 
 Thanmai                                                                _________________ 
 Paarvai                                                                  _________________ 
Sparisam                                                           _________________ 
Malam                                           Normal           Affected    
 Niram    
 Nurai    
 Elagal    
 Erugal    
Moothiram 
  Neerkuri                                  Normal              Affected    
Niram              
Edai              
Nurai              
Manam             
Enjal        
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  Neikuri 
  Vatham  
  Pitham 
  Kabam 
  Otherpattern 
Naadi: 
       Vadham       Pitham    Kabam 
                  Vatha pitham      Pitha vatham          Pitha kabam           
                  Vatha kabam      Kaba vatham          Kaba pitham 
DIAGOSIS : __________________________ 
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CLINICAL ASSESMENT (By modified vesikari scoring system) 
                                     
S.NO CLINICAL SYMPTOMS Before treatment After treatment 
1  Frequency of  loose stools   
2 Stool consistency   
3 Abdominal pain   
4 Fever   
        
Station: 
Signature of the Guide    Signature of the Investigator 
Date:  
Signature of the HOD    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA 
KAZHICHAL 
(BACILLARY DYSENTERY)  IN CHILDREN. 
FORM V – DRUG COMPLIANCE 
1. Sl. No:      2. OP / IP No:                      3. Name: 
4. Age:      5. Sex:                6. Date: 
7. Informant:      8. Reliablity: 
 
NAME OF THE DRUG                 : MOOKURATTAI  ENNAI 
FORM OF THE DRUG                  : LIQUID 
ADMINISTRATION                      :  PER ORAL 
DOSE & DURATION                     :  1.6 ml  (OD)FOR 3 DAYS 
   
     
 
DAY 
DATE OF          DRUG  
INTAKE 
MORNING 
 
 
DAY 1   
DAY2   
DAY 3   
  
Date: 
Station:                                                Signature of Principal 
Investigator: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
CLINICAL EVALUATION OF MOOKURATTAI ENNAI FOR KANA KAZHICHAL 
(BACILLARY DYSENTERY)  IN CHILDREN 
FORM VI: WITHDRAWAL 
1. Sl. No:        2. OP / IP No:                      3. Name:                                                  
4. Age:          5. Sex:   6. Date:       
7. Informant:                   8. Reliablity:   
Date of trial commencement   : 
Date of withdrawal from trial  : 
Reason(s) for withdrawal   :  
Long absence at reporting   : Yes / No 
Irregular treatment     : Yes / No 
Shift of locality                : Yes / No 
Complication /Adverse reactions if any : Yes / No 
Exacerbation of symptoms   : Yes / No 
Patient not willing to continue  : Yes / No 
 
Date:        
Station: 
 
Signature of the Guide     Signature of the 
Investigator 
  
Signature of the HOD                                                                 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF  MOOKURATTAI ENNAI  FOR 
KANAKAZHICHAL  IN CHILDREN. 
FORM VII-ADVERSE REACTION 
 
                                                   
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliablity: 
 
 
Name       : 
Age       : 
Gender    : 
OPD/ IPD No    : 
Registration No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
Date:        Signature of Principal 
Investigator 
                                     
1. Patient / consumer identification (please complete or tick boxes as appropriate) 
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  NATIONAL PHARMACOVIGILANCE PROGRAMME FOR  SIDDHA DRUGS 
 
 
Please note:   
i.  All consumers / patients and reporters information will remain confidential. 
ii. It is requested to report all suspected reactions to the concerned, even if it does 
not have  complete data, as soon as possible. 
1.Peripheral Center code:     State:   
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / Female  
Weight : 
Degam: 
  
2. Description of the suspected Adverse Reactions (please complete boxes below) 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
 
 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
Medicine 
Daily 
dose 
Route of 
administration 
& Vehicle – 
Adjuvant 
Date 
Diagnosis for 
which medicine 
taken 
Starting Stopped 
Siddha 
 
     
Any other 
system of 
medicines 
 
     
5. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug – 3 
a) Name of the medicine    
b) Manufacturing unit 
and batch No. and date 
   
c) Expiry date    
d) Purchased and 
obtained from 
   
e) Composition of the 
formulation / Part of the 
drug used 
   
a) Dietary Restrictions if any 
b) Whether the drug is consumed under Institutionally qualified medical 
supervision or used as self medication.  
c) Any other relevant information. 
5. Treatment provided for adverse reaction: 
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6. The result  of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
Reaction reappeared after re introduction: 
 
Was the patient admitted to hospital? 
If yes, give name and address of 
hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition    
Any Others  
 
9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / 
Attendant / Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name 
Address: 
Telephone / E – mail if any : 
 
Date:       Signature of the reporter:  
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Please send the completed form to:  
                The Director, 
                  National Institute of Siddha, 
                                                                       (Pharmacovigilance Regional Centre For Siddha Medicine), 
                                                                       Tambaram Sanatorium, Chennai-600 047. 
                                                                       ' (O) 044-22381314       Fax : 044 – 22381314 
              Website : www.nischennai.org 
              Email: nischennaisiddha@yahoo.co.in  
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * *  
This filled-in ADR report may be sent within one month of observation /occurrence of ADR 
   
 
 
 
Date:                                                                              
Station:  
 
 
Date:        
Station: 
 
Signature of the Guide     Signature of the 
Investigator 
  
Signature of the HOD                                                                 
 
Who Can Report?     
Þ Any Health care professionals like Siddha Doctors /  Nurses / 
Siddha Pharmacists / Patients etc.  
What to Report?  
Þ All reactions,  Drug interactions,  
Confidentiality  
Þ The patient’s identity will be held in strict confidence and protected 
to the fullest extent.  
Þ Submission of report will be taken up for remedial measures only 
not for legal claim  
Name & address of the RRC-ASU / 
PPC-ASU 
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